JP4533391B2 - 中枢神経系疾患の処置のための５−ヒドロキシトリプタミンレセプター（５−ｈｔ）のモジュレーターとしての、１−ベンジル−５−ピペラジン−１−イル−３，４−ジヒドロ−１ｈ−キナゾリン−２−オン誘導体、ならびにそれぞれの１ｈ−ベンゾ（１，２，６）チアジアジン−２，２−ジオキシドおよび１，４−ジヒドロベンゾ（ｄ）（１，３）オキサジン−２−オン誘導体 - Google Patents

Info

Publication number

JP4533391B2

JP4533391B2 JP2006548231A JP2006548231A JP4533391B2 JP 4533391 B2 JP4533391 B2 JP 4533391B2 JP 2006548231 A JP2006548231 A JP 2006548231A JP 2006548231 A JP2006548231 A JP 2006548231A JP 4533391 B2 JP4533391 B2 JP 4533391B2

Authority

JP

Japan

Prior art keywords

dihydro

benzyl

piperazin

quinazolin

compound

Prior art date

2004-01-16

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Expired - Fee Related

Links

• Espacenet
• Global Dossier
• Discuss

• 238000011282 treatment Methods 0.000 title claims description 22
• 208000015114 central nervous system disease Diseases 0.000 title claims description 5
• QDEHEDMGJOKOIM-UHFFFAOYSA-N 1-benzyl-5-piperazin-1-yl-3,4-dihydroquinazolin-2-one Chemical class O=C1NCC2=C(N3CCNCC3)C=CC=C2N1CC1=CC=CC=C1 QDEHEDMGJOKOIM-UHFFFAOYSA-N 0.000 title claims 2
• QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 title description 34
• 108091032151 5-hydroxytryptamine receptor family Proteins 0.000 title description 3
• 102000014630 G protein-coupled serotonin receptor activity proteins Human genes 0.000 title 2
• SYZIUAAQNFJPJY-UHFFFAOYSA-N 1,4-dihydro-3,1-benzoxazin-2-one Chemical class C1=CC=C2COC(=O)NC2=C1 SYZIUAAQNFJPJY-UHFFFAOYSA-N 0.000 title 1
• XCXVPQAXJPZYNW-UHFFFAOYSA-N 1h-2$l^{6},1,3-benzothiadiazine 2,2-dioxide Chemical compound C1=CC=C2C=NS(=O)(=O)NC2=C1 XCXVPQAXJPZYNW-UHFFFAOYSA-N 0.000 title 1
• 150000001875 compounds Chemical class 0.000 claims description 209
• -1 6- [1,4] diazepan-1-yl-2,2-dioxo-3,4-dihydro-2H-2λ 6 -benzo [1,2,6] thiadiazin-1-ylmethyl Chemical group 0.000 claims description 131
• 229910052739 hydrogen Inorganic materials 0.000 claims description 89
• 239000001257 hydrogen Substances 0.000 claims description 88
• 125000000217 alkyl group Chemical group 0.000 claims description 81
• 238000000034 method Methods 0.000 claims description 66
• UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 46
• 125000005843 halogen group Chemical group 0.000 claims description 42
• 150000002431 hydrogen Chemical class 0.000 claims description 34
• 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 33
• 125000003545 alkoxy group Chemical group 0.000 claims description 29
• 125000001188 haloalkyl group Chemical group 0.000 claims description 29
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 26
• CYRMSUTZVYGINF-UHFFFAOYSA-N trichlorofluoromethane Chemical compound FC(Cl)(Cl)Cl CYRMSUTZVYGINF-UHFFFAOYSA-N 0.000 claims description 25
• IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 23
• 201000010099 disease Diseases 0.000 claims description 23
• 229910052757 nitrogen Inorganic materials 0.000 claims description 20
• 125000004429 atom Chemical group 0.000 claims description 19
• 125000001153 fluoro group Chemical group F* 0.000 claims description 19
• 125000001072 heteroaryl group Chemical group 0.000 claims description 19
• 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 17
• 150000003839 salts Chemical class 0.000 claims description 16
• 125000004093 cyano group Chemical group *C#N 0.000 claims description 14
• 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 14
• 229910052799 carbon Inorganic materials 0.000 claims description 13
• 239000008194 pharmaceutical composition Substances 0.000 claims description 12
• 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 10
• 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 9
• 208000006096 Attention Deficit Disorder with Hyperactivity Diseases 0.000 claims description 8
• 125000002252 acyl group Chemical group 0.000 claims description 8
• 125000001309 chloro group Chemical group Cl* 0.000 claims description 8
• 125000004404 heteroalkyl group Chemical group 0.000 claims description 8
• 238000004519 manufacturing process Methods 0.000 claims description 8
• 125000001624 naphthyl group Chemical group 0.000 claims description 8
• 229910052717 sulfur Inorganic materials 0.000 claims description 8
• 125000004432 carbon atom Chemical group C* 0.000 claims description 7
• 239000003814 drug Substances 0.000 claims description 7
• 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 7
• 125000004204 2-methoxyphenyl group Chemical group [H]C1=C([H])C(*)=C(OC([H])([H])[H])C([H])=C1[H] 0.000 claims description 6
• 125000004207 3-methoxyphenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(OC([H])([H])[H])=C1[H] 0.000 claims description 6
• 125000004801 4-cyanophenyl group Chemical group [H]C1=C([H])C(C#N)=C([H])C([H])=C1* 0.000 claims description 6
• 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 claims description 6
• 208000036864 Attention deficit/hyperactivity disease Diseases 0.000 claims description 6
• 208000018522 Gastrointestinal disease Diseases 0.000 claims description 6
• 208000015802 attention deficit-hyperactivity disease Diseases 0.000 claims description 6
• 208000035231 inattentive type attention deficit hyperactivity disease Diseases 0.000 claims description 6
• 125000003261 o-tolyl group Chemical group [H]C1=C([H])C(*)=C(C([H])=C1[H])C([H])([H])[H] 0.000 claims description 6
• QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 5
• 125000002768 hydroxyalkyl group Chemical group 0.000 claims description 5
• 125000003107 substituted aryl group Chemical group 0.000 claims description 5
• BKDZLPRBGFRWFR-UHFFFAOYSA-N 1-[(3-fluorophenyl)methyl]-7-methoxy-5-piperazin-1-yl-3,4-dihydroquinazolin-2-one Chemical compound C=12CNC(=O)N(CC=3C=C(F)C=CC=3)C2=CC(OC)=CC=1N1CCNCC1 BKDZLPRBGFRWFR-UHFFFAOYSA-N 0.000 claims description 4
• MXGLXHPGMCBMAK-UHFFFAOYSA-N 1-benzyl-5-piperazin-1-yl-4h-3,1-benzoxazin-2-one Chemical compound O=C1OCC2=C(N3CCNCC3)C=CC=C2N1CC1=CC=CC=C1 MXGLXHPGMCBMAK-UHFFFAOYSA-N 0.000 claims description 4
• 208000024827 Alzheimer disease Diseases 0.000 claims description 4
• 208000020925 Bipolar disease Diseases 0.000 claims description 4
• 208000023105 Huntington disease Diseases 0.000 claims description 4
• 208000018737 Parkinson disease Diseases 0.000 claims description 4
• 208000028017 Psychotic disease Diseases 0.000 claims description 4
• 125000004183 alkoxy alkyl group Chemical group 0.000 claims description 4
• 208000028683 bipolar I disease Diseases 0.000 claims description 4
• 239000003937 drug carrier Substances 0.000 claims description 4
• 125000000040 m-tolyl group Chemical group [H]C1=C([H])C(*)=C([H])C(=C1[H])C([H])([H])[H] 0.000 claims description 4
• 201000000980 schizophrenia Diseases 0.000 claims description 4
• PJDFWQSESQKQNK-UHFFFAOYSA-N 1-[(3-fluorophenyl)methyl]-3-methyl-5-piperazin-1-yl-4h-quinazolin-2-one Chemical compound O=C1N(C)CC2=C(N3CCNCC3)C=CC=C2N1CC1=CC=CC(F)=C1 PJDFWQSESQKQNK-UHFFFAOYSA-N 0.000 claims description 3
• UCKBESNKIBVXOX-UHFFFAOYSA-N 1-[(4-fluorophenyl)methyl]-5-piperazin-1-yl-3,4-dihydroquinazolin-2-one Chemical compound C1=CC(F)=CC=C1CN1C2=CC=CC(N3CCNCC3)=C2CNC1=O UCKBESNKIBVXOX-UHFFFAOYSA-N 0.000 claims description 3
• NDGXDCQTFHASLS-UHFFFAOYSA-N 1-benzyl-3-methyl-5-piperazin-1-yl-4h-2$l^{6},1,3-benzothiadiazine 2,2-dioxide Chemical compound O=S1(=O)N(C)CC2=C(N3CCNCC3)C=CC=C2N1CC1=CC=CC=C1 NDGXDCQTFHASLS-UHFFFAOYSA-N 0.000 claims description 3
• OAMKXXZOKAQMFE-UHFFFAOYSA-N 1-benzyl-6-fluoro-5-piperazin-1-yl-3,4-dihydroquinazolin-2-one Chemical compound O=C1NCC2=C(N3CCNCC3)C(F)=CC=C2N1CC1=CC=CC=C1 OAMKXXZOKAQMFE-UHFFFAOYSA-N 0.000 claims description 3
• 208000035475 disorder Diseases 0.000 claims description 3
• STWAAXRCUIUVEV-UHFFFAOYSA-N 1-[(2,3-difluorophenyl)methyl]-7-ethyl-5-piperazin-1-yl-3,4-dihydroquinazolin-2-one Chemical compound C=12CNC(=O)N(CC=3C(=C(F)C=CC=3)F)C2=CC(CC)=CC=1N1CCNCC1 STWAAXRCUIUVEV-UHFFFAOYSA-N 0.000 claims description 2
• LQXBXVDFUCCDJA-UHFFFAOYSA-N 1-benzyl-5-piperazin-1-yl-3,4-dihydro-2$l^{6},1,3-benzothiadiazine 2,2-dioxide Chemical compound O=S1(=O)NCC2=C(N3CCNCC3)C=CC=C2N1CC1=CC=CC=C1 LQXBXVDFUCCDJA-UHFFFAOYSA-N 0.000 claims description 2
• 206010002026 amyotrophic lateral sclerosis Diseases 0.000 claims description 2
• 206010027175 memory impairment Diseases 0.000 claims description 2
• 201000001119 neuropathy Diseases 0.000 claims description 2
• 230000007823 neuropathy Effects 0.000 claims description 2
• 208000033808 peripheral neuropathy Diseases 0.000 claims description 2
• PQZIROVGCOLSGN-UHFFFAOYSA-N 1-[(2-methylphenyl)methyl]-5-piperazin-1-yl-3,4-dihydroquinazolin-2-one Chemical compound CC1=CC=CC=C1CN1C2=CC=CC(N3CCNCC3)=C2CNC1=O PQZIROVGCOLSGN-UHFFFAOYSA-N 0.000 claims 2
• AFGKWQWJPYQERS-UHFFFAOYSA-N 1-[(3-chlorophenyl)methyl]-5-piperazin-1-yl-3,4-dihydro-2$l^{6},1,3-benzothiadiazine 2,2-dioxide Chemical compound ClC1=CC=CC(CN2S(NCC3=C(N4CCNCC4)C=CC=C32)(=O)=O)=C1 AFGKWQWJPYQERS-UHFFFAOYSA-N 0.000 claims 2
• VXZJWJHIPBYIQW-UHFFFAOYSA-N 1-[(3-fluorophenyl)methyl]-5-piperazin-1-yl-3,4-dihydro-2$l^{6},1,3-benzothiadiazine 2,2-dioxide Chemical compound FC1=CC=CC(CN2S(NCC3=C(N4CCNCC4)C=CC=C32)(=O)=O)=C1 VXZJWJHIPBYIQW-UHFFFAOYSA-N 0.000 claims 2
• MDKXZMBGVZHRCL-UHFFFAOYSA-N 1-[(3-fluorophenyl)methyl]-5-piperazin-1-yl-3,4-dihydroquinazolin-2-one Chemical compound FC1=CC=CC(CN2C3=CC=CC(=C3CNC2=O)N2CCNCC2)=C1 MDKXZMBGVZHRCL-UHFFFAOYSA-N 0.000 claims 2
• 125000003852 3-chlorobenzyl group Chemical group [H]C1=C([H])C(=C([H])C(Cl)=C1[H])C([H])([H])* 0.000 claims 2
• RUOOEFDLFQQWNN-UHFFFAOYSA-N 1-[(2,2-dimethyl-3h-1-benzofuran-7-yl)methyl]-5-piperazin-1-yl-3,4-dihydroquinazolin-2-one Chemical compound C=12OC(C)(C)CC2=CC=CC=1CN(C1=CC=C2)C(=O)NCC1=C2N1CCNCC1 RUOOEFDLFQQWNN-UHFFFAOYSA-N 0.000 claims 1
• AZVOVHHXZRNPDQ-UHFFFAOYSA-N 1-[(2,3-dichlorophenyl)methyl]-5-piperazin-1-yl-3,4-dihydro-2$l^{6},1,3-benzothiadiazine 2,2-dioxide Chemical compound ClC1=CC=CC(CN2S(NCC3=C(N4CCNCC4)C=CC=C32)(=O)=O)=C1Cl AZVOVHHXZRNPDQ-UHFFFAOYSA-N 0.000 claims 1
• CQGNOOPIHCBULX-UHFFFAOYSA-N 1-[(2,3-dichlorophenyl)methyl]-5-piperazin-1-yl-3,4-dihydroquinazolin-2-one Chemical compound ClC1=CC=CC(CN2C3=CC=CC(=C3CNC2=O)N2CCNCC2)=C1Cl CQGNOOPIHCBULX-UHFFFAOYSA-N 0.000 claims 1
• ZREQQLIQGVXRAC-UHFFFAOYSA-N 1-[(2,3-difluorophenyl)methyl]-5-piperazin-1-yl-3,4-dihydro-2$l^{6},1,3-benzothiadiazine 2,2-dioxide Chemical compound FC1=CC=CC(CN2S(NCC3=C(N4CCNCC4)C=CC=C32)(=O)=O)=C1F ZREQQLIQGVXRAC-UHFFFAOYSA-N 0.000 claims 1
• VUOAIRCNUMVRAS-UHFFFAOYSA-N 1-[(2,3-difluorophenyl)methyl]-5-piperazin-1-yl-3,4-dihydroquinazolin-2-one Chemical compound FC1=CC=CC(CN2C3=CC=CC(=C3CNC2=O)N2CCNCC2)=C1F VUOAIRCNUMVRAS-UHFFFAOYSA-N 0.000 claims 1
• ZNGROUCDEQNFLF-UHFFFAOYSA-N 1-[(2,3-difluorophenyl)methyl]-5-piperazin-1-yl-3-propan-2-yl-4h-quinazolin-2-one Chemical compound O=C1N(C(C)C)CC2=C(N3CCNCC3)C=CC=C2N1CC1=CC=CC(F)=C1F ZNGROUCDEQNFLF-UHFFFAOYSA-N 0.000 claims 1
• KLXLOSKMWXJFBN-UHFFFAOYSA-N 1-[(2,3-dimethylphenyl)methyl]-5-piperazin-1-yl-3,4-dihydroquinazolin-2-one Chemical compound CC1=CC=CC(CN2C3=CC=CC(=C3CNC2=O)N2CCNCC2)=C1C KLXLOSKMWXJFBN-UHFFFAOYSA-N 0.000 claims 1
• BILAYTJFTUXXQI-UHFFFAOYSA-N 1-[(2,6-difluorophenyl)methyl]-5-piperazin-1-yl-3,4-dihydroquinazolin-2-one Chemical compound FC1=CC=CC(F)=C1CN1C2=CC=CC(N3CCNCC3)=C2CNC1=O BILAYTJFTUXXQI-UHFFFAOYSA-N 0.000 claims 1
• QLQKILNYYBQJMI-UHFFFAOYSA-N 1-[(2,6-difluorophenyl)methyl]-7-ethyl-5-piperazin-1-yl-3,4-dihydroquinazolin-2-one Chemical compound C=12CNC(=O)N(CC=3C(=CC=CC=3F)F)C2=CC(CC)=CC=1N1CCNCC1 QLQKILNYYBQJMI-UHFFFAOYSA-N 0.000 claims 1
• HKUVDSQISIOHAM-UHFFFAOYSA-N 1-[(2,6-dimethylphenyl)methyl]-5-piperazin-1-yl-3,4-dihydroquinazolin-2-one Chemical compound CC1=CC=CC(C)=C1CN1C2=CC=CC(N3CCNCC3)=C2CNC1=O HKUVDSQISIOHAM-UHFFFAOYSA-N 0.000 claims 1
• UONKZBXKMRVFEM-UHFFFAOYSA-N 1-[(2-chlorophenyl)methyl]-5-piperazin-1-yl-3,4-dihydro-2$l^{6},1,3-benzothiadiazine 2,2-dioxide Chemical compound ClC1=CC=CC=C1CN1S(=O)(=O)NCC2=C(N3CCNCC3)C=CC=C21 UONKZBXKMRVFEM-UHFFFAOYSA-N 0.000 claims 1
• FTMAFOYMGFSILB-UHFFFAOYSA-N 1-[(2-chlorophenyl)methyl]-5-piperazin-1-yl-3,4-dihydroquinazolin-2-one Chemical compound ClC1=CC=CC=C1CN1C2=CC=CC(N3CCNCC3)=C2CNC1=O FTMAFOYMGFSILB-UHFFFAOYSA-N 0.000 claims 1
• XHNOWLDNPRGPJS-UHFFFAOYSA-N 1-[(2-chlorophenyl)methyl]-7-ethyl-5-piperazin-1-yl-3,4-dihydroquinazolin-2-one Chemical compound C=12CNC(=O)N(CC=3C(=CC=CC=3)Cl)C2=CC(CC)=CC=1N1CCNCC1 XHNOWLDNPRGPJS-UHFFFAOYSA-N 0.000 claims 1
• VUYNORRXANKUQP-UHFFFAOYSA-N 1-[(2-chlorophenyl)methyl]-7-methyl-5-piperazin-1-yl-3,4-dihydroquinazolin-2-one Chemical compound C=12CNC(=O)N(CC=3C(=CC=CC=3)Cl)C2=CC(C)=CC=1N1CCNCC1 VUYNORRXANKUQP-UHFFFAOYSA-N 0.000 claims 1
• HDXMPQDSOJJFFH-UHFFFAOYSA-N 1-[(2-fluorophenyl)methyl]-3-methyl-5-piperazin-1-yl-4h-quinazolin-2-one Chemical compound O=C1N(C)CC2=C(N3CCNCC3)C=CC=C2N1CC1=CC=CC=C1F HDXMPQDSOJJFFH-UHFFFAOYSA-N 0.000 claims 1
• SSWQMGFCFOHHJV-UHFFFAOYSA-N 1-[(2-fluorophenyl)methyl]-5-piperazin-1-yl-3,4-dihydro-2$l^{6},1,3-benzothiadiazine 2,2-dioxide Chemical compound FC1=CC=CC=C1CN1S(=O)(=O)NCC2=C(N3CCNCC3)C=CC=C21 SSWQMGFCFOHHJV-UHFFFAOYSA-N 0.000 claims 1
• ZYFGPTIXKRIOIL-UHFFFAOYSA-N 1-[(2-fluorophenyl)methyl]-5-piperazin-1-yl-3,4-dihydroquinazolin-2-one Chemical compound FC1=CC=CC=C1CN1C2=CC=CC(N3CCNCC3)=C2CNC1=O ZYFGPTIXKRIOIL-UHFFFAOYSA-N 0.000 claims 1
• NBCLWVINBHJRAF-UHFFFAOYSA-N 1-[(2-fluorophenyl)methyl]-5-piperazin-1-yl-3-propan-2-yl-4h-quinazolin-2-one Chemical compound O=C1N(C(C)C)CC2=C(N3CCNCC3)C=CC=C2N1CC1=CC=CC=C1F NBCLWVINBHJRAF-UHFFFAOYSA-N 0.000 claims 1
• PEAADNBWFCCMCV-UHFFFAOYSA-N 1-[(2-fluorophenyl)methyl]-5-piperazin-1-yl-4h-3,1-benzoxazin-2-one Chemical compound FC1=CC=CC=C1CN1C2=CC=CC(N3CCNCC3)=C2COC1=O PEAADNBWFCCMCV-UHFFFAOYSA-N 0.000 claims 1
• AEZNVTOBDUUZAK-UHFFFAOYSA-N 1-[(2-fluorophenyl)methyl]-5-piperazin-1-yl-7-(trifluoromethyl)-3,4-dihydroquinazolin-2-one Chemical compound FC1=CC=CC=C1CN1C2=CC(C(F)(F)F)=CC(N3CCNCC3)=C2CNC1=O AEZNVTOBDUUZAK-UHFFFAOYSA-N 0.000 claims 1
• OHPGAQPVVXBWIF-UHFFFAOYSA-N 1-[(2-fluorophenyl)methyl]-7-methyl-5-(4-methylpiperazin-1-yl)-3,4-dihydroquinazolin-2-one Chemical compound C1CN(C)CCN1C1=CC(C)=CC2=C1CNC(=O)N2CC1=CC=CC=C1F OHPGAQPVVXBWIF-UHFFFAOYSA-N 0.000 claims 1
• DTDSTZIIFOWMRJ-UHFFFAOYSA-N 1-[(2-fluorophenyl)methyl]-7-methyl-5-piperazin-1-yl-3,4-dihydroquinazolin-2-one Chemical compound C=12CNC(=O)N(CC=3C(=CC=CC=3)F)C2=CC(C)=CC=1N1CCNCC1 DTDSTZIIFOWMRJ-UHFFFAOYSA-N 0.000 claims 1
• PWABCZZTBYQOBO-UHFFFAOYSA-N 1-[(2-methylphenyl)methyl]-5-piperazin-1-yl-3,4-dihydro-2$l^{6},1,3-benzothiadiazine 2,2-dioxide Chemical compound CC1=CC=CC=C1CN1S(=O)(=O)NCC2=C(N3CCNCC3)C=CC=C21 PWABCZZTBYQOBO-UHFFFAOYSA-N 0.000 claims 1
• DURHUMGTSMUEIR-UHFFFAOYSA-N 1-[(3,4-dichlorophenyl)methyl]-5-piperazin-1-yl-3,4-dihydro-2$l^{6},1,3-benzothiadiazine 2,2-dioxide Chemical compound C1=C(Cl)C(Cl)=CC=C1CN1S(=O)(=O)NCC2=C(N3CCNCC3)C=CC=C21 DURHUMGTSMUEIR-UHFFFAOYSA-N 0.000 claims 1
• WFFJMKOOVQAKMJ-UHFFFAOYSA-N 1-[(3,4-dichlorophenyl)methyl]-5-piperazin-1-yl-3,4-dihydroquinazolin-2-one Chemical compound C1=C(Cl)C(Cl)=CC=C1CN1C2=CC=CC(N3CCNCC3)=C2CNC1=O WFFJMKOOVQAKMJ-UHFFFAOYSA-N 0.000 claims 1
• HRKGKFMKQUHQKW-UHFFFAOYSA-N 1-[(3,4-difluorophenyl)methyl]-5-piperazin-1-yl-3,4-dihydroquinazolin-2-one Chemical compound C1=C(F)C(F)=CC=C1CN1C2=CC=CC(N3CCNCC3)=C2CNC1=O HRKGKFMKQUHQKW-UHFFFAOYSA-N 0.000 claims 1
• VQAUFXIQDMQEPX-UHFFFAOYSA-N 1-[(3-chloro-2-fluorophenyl)methyl]-5-piperazin-1-yl-3,4-dihydro-2$l^{6},1,3-benzothiadiazine 2,2-dioxide Chemical compound FC1=C(Cl)C=CC=C1CN1S(=O)(=O)NCC2=C(N3CCNCC3)C=CC=C21 VQAUFXIQDMQEPX-UHFFFAOYSA-N 0.000 claims 1
• VLBNZRWSPFXRLV-UHFFFAOYSA-N 1-[(3-chloro-2-fluorophenyl)methyl]-5-piperazin-1-yl-3,4-dihydroquinazolin-2-one Chemical compound FC1=C(Cl)C=CC=C1CN1C2=CC=CC(N3CCNCC3)=C2CNC1=O VLBNZRWSPFXRLV-UHFFFAOYSA-N 0.000 claims 1
• CNEXRAAANDGMPR-UHFFFAOYSA-N 1-[(3-chlorophenyl)methyl]-5-piperazin-1-yl-3,4-dihydroquinazolin-2-one Chemical compound ClC1=CC=CC(CN2C3=CC=CC(=C3CNC2=O)N2CCNCC2)=C1 CNEXRAAANDGMPR-UHFFFAOYSA-N 0.000 claims 1
• WFBSULFTDHFZCY-UHFFFAOYSA-N 1-[(3-chlorophenyl)methyl]-7-ethyl-5-piperazin-1-yl-3,4-dihydroquinazolin-2-one Chemical compound C=12CNC(=O)N(CC=3C=C(Cl)C=CC=3)C2=CC(CC)=CC=1N1CCNCC1 WFBSULFTDHFZCY-UHFFFAOYSA-N 0.000 claims 1
• COSPLTUHJCIOQN-UHFFFAOYSA-N 1-[(3-fluorophenyl)methyl]-5-(4-methylpiperazin-1-yl)-3,4-dihydroquinazolin-2-one Chemical compound C1CN(C)CCN1C1=CC=CC2=C1CNC(=O)N2CC1=CC=CC(F)=C1 COSPLTUHJCIOQN-UHFFFAOYSA-N 0.000 claims 1
• WJMOBCPZXTZDDM-UHFFFAOYSA-N 1-[(3-fluorophenyl)methyl]-5-piperazin-1-yl-3-propan-2-yl-4h-quinazolin-2-one Chemical compound O=C1N(C(C)C)CC2=C(N3CCNCC3)C=CC=C2N1CC1=CC=CC(F)=C1 WJMOBCPZXTZDDM-UHFFFAOYSA-N 0.000 claims 1
• CZRPTAXTPDFGFM-UHFFFAOYSA-N 1-[(3-fluorophenyl)methyl]-5-piperazin-1-yl-4h-3,1-benzoxazin-2-one Chemical compound FC1=CC=CC(CN2C3=CC=CC(=C3COC2=O)N2CCNCC2)=C1 CZRPTAXTPDFGFM-UHFFFAOYSA-N 0.000 claims 1
• KDPYLJANQNSJEK-UHFFFAOYSA-N 1-[(3-fluorophenyl)methyl]-5-piperazin-1-yl-7-(trifluoromethyl)-3,4-dihydroquinazolin-2-one Chemical compound FC1=CC=CC(CN2C3=CC(=CC(=C3CNC2=O)N2CCNCC2)C(F)(F)F)=C1 KDPYLJANQNSJEK-UHFFFAOYSA-N 0.000 claims 1
• ICFIZPGUDQIOQG-UHFFFAOYSA-N 1-[(3-fluorophenyl)methyl]-7-methyl-5-piperazin-1-yl-3,4-dihydroquinazolin-2-one Chemical compound C=12CNC(=O)N(CC=3C=C(F)C=CC=3)C2=CC(C)=CC=1N1CCNCC1 ICFIZPGUDQIOQG-UHFFFAOYSA-N 0.000 claims 1
• LGRNEPWCKFRPPA-UHFFFAOYSA-N 1-[(4-chlorophenyl)methyl]-5-piperazin-1-yl-3,4-dihydro-2$l^{6},1,3-benzothiadiazine 2,2-dioxide Chemical compound C1=CC(Cl)=CC=C1CN1S(=O)(=O)NCC2=C(N3CCNCC3)C=CC=C21 LGRNEPWCKFRPPA-UHFFFAOYSA-N 0.000 claims 1
• WGZRGWPASCNABE-UHFFFAOYSA-N 1-[(4-chlorophenyl)methyl]-5-piperazin-1-yl-3,4-dihydroquinazolin-2-one Chemical compound C1=CC(Cl)=CC=C1CN1C2=CC=CC(N3CCNCC3)=C2CNC1=O WGZRGWPASCNABE-UHFFFAOYSA-N 0.000 claims 1
• WZCIGDURTXEHFY-UHFFFAOYSA-N 1-[(4-fluorophenyl)methyl]-3-methyl-5-piperazin-1-yl-4h-quinazolin-2-one Chemical compound O=C1N(C)CC2=C(N3CCNCC3)C=CC=C2N1CC1=CC=C(F)C=C1 WZCIGDURTXEHFY-UHFFFAOYSA-N 0.000 claims 1
• NEJULOZWVLPODE-UHFFFAOYSA-N 1-[(4-fluorophenyl)methyl]-5-piperazin-1-yl-3,4-dihydro-2$l^{6},1,3-benzothiadiazine 2,2-dioxide Chemical compound C1=CC(F)=CC=C1CN1S(=O)(=O)NCC2=C(N3CCNCC3)C=CC=C21 NEJULOZWVLPODE-UHFFFAOYSA-N 0.000 claims 1
• VTFBLDKNJLBVPJ-UHFFFAOYSA-N 1-[(4-fluorophenyl)methyl]-5-piperazin-1-yl-3-propan-2-yl-4h-quinazolin-2-one Chemical compound O=C1N(C(C)C)CC2=C(N3CCNCC3)C=CC=C2N1CC1=CC=C(F)C=C1 VTFBLDKNJLBVPJ-UHFFFAOYSA-N 0.000 claims 1
• XGYMOMRCZKFJGG-UHFFFAOYSA-N 1-benzyl-3-ethyl-5-piperazin-1-yl-4h-quinazolin-2-one Chemical compound O=C1N(CC)CC2=C(N3CCNCC3)C=CC=C2N1CC1=CC=CC=C1 XGYMOMRCZKFJGG-UHFFFAOYSA-N 0.000 claims 1
• VMHWBQZTFACGHZ-UHFFFAOYSA-N 1-benzyl-3-methyl-5-piperazin-1-yl-4h-quinazolin-2-one Chemical compound O=C1N(C)CC2=C(N3CCNCC3)C=CC=C2N1CC1=CC=CC=C1 VMHWBQZTFACGHZ-UHFFFAOYSA-N 0.000 claims 1
• ULQQHZGKMZWFDD-UHFFFAOYSA-N 1-benzyl-5-piperazin-1-yl-3-propan-2-yl-4h-quinazolin-2-one Chemical compound O=C1N(C(C)C)CC2=C(N3CCNCC3)C=CC=C2N1CC1=CC=CC=C1 ULQQHZGKMZWFDD-UHFFFAOYSA-N 0.000 claims 1
• RPPKAAXCQQTHKG-UHFFFAOYSA-N 1-benzyl-5-piperazin-1-yl-7-(trifluoromethyl)-3,4-dihydroquinazolin-2-one Chemical compound C=12CNC(=O)N(CC=3C=CC=CC=3)C2=CC(C(F)(F)F)=CC=1N1CCNCC1 RPPKAAXCQQTHKG-UHFFFAOYSA-N 0.000 claims 1
• RVGXECDQOALXBM-UHFFFAOYSA-N 1-benzyl-7-ethyl-5-piperazin-1-yl-3,4-dihydroquinazolin-2-one Chemical compound C=12CNC(=O)N(CC=3C=CC=CC=3)C2=CC(CC)=CC=1N1CCNCC1 RVGXECDQOALXBM-UHFFFAOYSA-N 0.000 claims 1
• IHRSNZQEIJEURL-UHFFFAOYSA-N 2-(1-benzyl-2-oxo-5-piperazin-1-yl-4h-quinazolin-3-yl)acetamide Chemical compound O=C1N(CC(=O)N)CC2=C(N3CCNCC3)C=CC=C2N1CC1=CC=CC=C1 IHRSNZQEIJEURL-UHFFFAOYSA-N 0.000 claims 1
• UJRJSYUWMCFBGY-UHFFFAOYSA-N 2-[1-[(3-fluorophenyl)methyl]-2-oxo-5-piperazin-1-yl-4h-quinazolin-3-yl]acetamide Chemical compound O=C1N(CC(=O)N)CC2=C(N3CCNCC3)C=CC=C2N1CC1=CC=CC(F)=C1 UJRJSYUWMCFBGY-UHFFFAOYSA-N 0.000 claims 1
• HSBCWXOUIRFTQI-UHFFFAOYSA-N 3-[(3-methyl-2-oxo-5-piperazin-1-yl-4h-quinazolin-1-yl)methyl]benzonitrile Chemical compound O=C1N(C)CC2=C(N3CCNCC3)C=CC=C2N1CC1=CC=CC(C#N)=C1 HSBCWXOUIRFTQI-UHFFFAOYSA-N 0.000 claims 1
• AVHXBQMVNSHORV-UHFFFAOYSA-N 3-ethyl-1-[(4-fluorophenyl)methyl]-5-piperazin-1-yl-4h-quinazolin-2-one Chemical compound O=C1N(CC)CC2=C(N3CCNCC3)C=CC=C2N1CC1=CC=C(F)C=C1 AVHXBQMVNSHORV-UHFFFAOYSA-N 0.000 claims 1
• MWGFWHUKFODITF-UHFFFAOYSA-N 7-ethyl-1-[(2-fluorophenyl)methyl]-5-piperazin-1-yl-3,4-dihydroquinazolin-2-one Chemical compound C=12CNC(=O)N(CC=3C(=CC=CC=3)F)C2=CC(CC)=CC=1N1CCNCC1 MWGFWHUKFODITF-UHFFFAOYSA-N 0.000 claims 1
• NYFQYWSXAOMRLV-UHFFFAOYSA-N 7-ethyl-1-[(3-fluorophenyl)methyl]-5-piperazin-1-yl-3,4-dihydroquinazolin-2-one Chemical compound C=12CNC(=O)N(CC=3C=C(F)C=CC=3)C2=CC(CC)=CC=1N1CCNCC1 NYFQYWSXAOMRLV-UHFFFAOYSA-N 0.000 claims 1
• OCLPRALFZDEMMK-UHFFFAOYSA-N 7-ethyl-5-piperazin-1-yl-1-[[2-(trifluoromethyl)phenyl]methyl]-3,4-dihydroquinazolin-2-one Chemical compound C=12CNC(=O)N(CC=3C(=CC=CC=3)C(F)(F)F)C2=CC(CC)=CC=1N1CCNCC1 OCLPRALFZDEMMK-UHFFFAOYSA-N 0.000 claims 1
• 230000037406 food intake Effects 0.000 claims 1
• 235000012631 food intake Nutrition 0.000 claims 1
• URXJHZXEUUFNKM-UHFFFAOYSA-N naphthalene-2-carboximidamide Chemical compound C1=CC=CC2=CC(C(=N)N)=CC=C21 URXJHZXEUUFNKM-UHFFFAOYSA-N 0.000 claims 1
• XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 124
• 239000000243 solution Substances 0.000 description 65
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 49
• 239000000203 mixture Substances 0.000 description 47
• 235000019439 ethyl acetate Nutrition 0.000 description 42
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 39
• ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 32
• 238000006243 chemical reaction Methods 0.000 description 32
• OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 28
• 239000007787 solid Substances 0.000 description 28
• WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 26
• 239000011541 reaction mixture Substances 0.000 description 26
• VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 25
• YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 21
• 230000008569 process Effects 0.000 description 21
• CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 20
• VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 19
• 239000000843 powder Substances 0.000 description 17
• 239000002904 solvent Substances 0.000 description 17
• 125000003118 aryl group Chemical group 0.000 description 16
• 238000009472 formulation Methods 0.000 description 16
• YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 15
• 239000012267 brine Substances 0.000 description 15
• HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 15
• 239000004480 active ingredient Substances 0.000 description 14
• 238000001035 drying Methods 0.000 description 14
• 238000003818 flash chromatography Methods 0.000 description 14
• 238000002360 preparation method Methods 0.000 description 14
• 229960004756 ethanol Drugs 0.000 description 13
• AVRPFRMDMNDIDH-UHFFFAOYSA-N 1h-quinazolin-2-one Chemical group C1=CC=CC2=NC(O)=NC=C21 AVRPFRMDMNDIDH-UHFFFAOYSA-N 0.000 description 12
• 238000003756 stirring Methods 0.000 description 12
• KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 11
• 125000000753 cycloalkyl group Chemical group 0.000 description 11
• 239000002552 dosage form Substances 0.000 description 11
• 239000003826 tablet Substances 0.000 description 11
• OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 10
• 239000002585 base Substances 0.000 description 10
• 229910052943 magnesium sulfate Inorganic materials 0.000 description 10
• 235000019341 magnesium sulphate Nutrition 0.000 description 10
• 239000000651 prodrug Substances 0.000 description 10
• 229940002612 prodrug Drugs 0.000 description 10
• 102000005962 receptors Human genes 0.000 description 10
• 108020003175 receptors Proteins 0.000 description 10
• 239000012453 solvate Substances 0.000 description 10
• QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
• CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 9
• KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 9
• ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 9
• 230000027455 binding Effects 0.000 description 9
• 239000002775 capsule Substances 0.000 description 9
• 125000000623 heterocyclic group Chemical group 0.000 description 9
• 239000012044 organic layer Substances 0.000 description 9
• 125000001424 substituent group Chemical group 0.000 description 9
• 239000000725 suspension Substances 0.000 description 9
• RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 8
• JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 8
• 125000001316 cycloalkyl alkyl group Chemical group 0.000 description 8
• 239000004615 ingredient Substances 0.000 description 8
• 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 8
• 238000010992 reflux Methods 0.000 description 8
• 238000005576 amination reaction Methods 0.000 description 7
• 238000004440 column chromatography Methods 0.000 description 7
• QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 7
• 229920006395 saturated elastomer Polymers 0.000 description 7
• 229940124530 sulfonamide Drugs 0.000 description 7
• UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
• OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 6
• 241000124008 Mammalia Species 0.000 description 6
• DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
• VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 6
• 239000002253 acid Substances 0.000 description 6
• WGQKYBSKWIADBV-UHFFFAOYSA-N aminomethyl benzene Natural products NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 description 6
• KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
• 239000000543 intermediate Substances 0.000 description 6
• 229910052760 oxygen Inorganic materials 0.000 description 6
• 125000006239 protecting group Chemical group 0.000 description 6
• 239000002287 radioligand Substances 0.000 description 6
• CWXPZXBSDSIRCS-UHFFFAOYSA-N tert-butyl piperazine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCNCC1 CWXPZXBSDSIRCS-UHFFFAOYSA-N 0.000 description 6
• YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 6
• 125000001984 thiazolidinyl group Chemical group 0.000 description 6
• UCPYLLCMEDAXFR-UHFFFAOYSA-N triphosgene Chemical compound ClC(Cl)(Cl)OC(=O)OC(Cl)(Cl)Cl UCPYLLCMEDAXFR-UHFFFAOYSA-N 0.000 description 6
• 238000007126 N-alkylation reaction Methods 0.000 description 5
• PAYRUJLWNCNPSJ-UHFFFAOYSA-N N-phenyl amine Natural products NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 5
• FFBHFFJDDLITSX-UHFFFAOYSA-N benzyl N-[2-hydroxy-4-(3-oxomorpholin-4-yl)phenyl]carbamate Chemical compound OC1=C(NC(=O)OCC2=CC=CC=C2)C=CC(=C1)N1CCOCC1=O FFBHFFJDDLITSX-UHFFFAOYSA-N 0.000 description 5
• 210000004027 cell Anatomy 0.000 description 5
• 239000003153 chemical reaction reagent Substances 0.000 description 5
• 239000000839 emulsion Substances 0.000 description 5
• 125000005549 heteroarylene group Chemical group 0.000 description 5
• 150000002430 hydrocarbons Chemical group 0.000 description 5
• FPCCSQOGAWCVBH-UHFFFAOYSA-N ketanserin Chemical compound C1=CC(F)=CC=C1C(=O)C1CCN(CCN2C(C3=CC=CC=C3NC2=O)=O)CC1 FPCCSQOGAWCVBH-UHFFFAOYSA-N 0.000 description 5
• 239000010410 layer Substances 0.000 description 5
• 239000003446 ligand Substances 0.000 description 5
• 239000007788 liquid Substances 0.000 description 5
• 238000002844 melting Methods 0.000 description 5
• 230000008018 melting Effects 0.000 description 5
• 239000001301 oxygen Substances 0.000 description 5
• 239000003880 polar aprotic solvent Substances 0.000 description 5
• 230000009467 reduction Effects 0.000 description 5
• 208000024891 symptom Diseases 0.000 description 5
• 238000012360 testing method Methods 0.000 description 5
• JCBTXEUYUWGIMU-UHFFFAOYSA-N 1-bromo-2-(bromomethyl)-3-nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC(Br)=C1CBr JCBTXEUYUWGIMU-UHFFFAOYSA-N 0.000 description 4
• GQVVUUVQKDEZEA-UHFFFAOYSA-N 3-bromo-2-(methylaminomethyl)aniline Chemical compound CNCC1=C(N)C=CC=C1Br GQVVUUVQKDEZEA-UHFFFAOYSA-N 0.000 description 4
• SNJNVLHIFSWKBF-UHFFFAOYSA-N 4-fluoro-2,6-dinitrobenzonitrile Chemical compound [O-][N+](=O)C1=CC(F)=CC([N+]([O-])=O)=C1C#N SNJNVLHIFSWKBF-UHFFFAOYSA-N 0.000 description 4
• LSNDMCKIYVEPIE-UHFFFAOYSA-N 4-methoxy-2,6-dinitrobenzonitrile Chemical compound COC1=CC([N+]([O-])=O)=C(C#N)C([N+]([O-])=O)=C1 LSNDMCKIYVEPIE-UHFFFAOYSA-N 0.000 description 4
• 108091005435 5-HT6 receptors Proteins 0.000 description 4
• AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 4
• YGYAWVDWMABLBF-UHFFFAOYSA-N Phosgene Chemical compound ClC(Cl)=O YGYAWVDWMABLBF-UHFFFAOYSA-N 0.000 description 4
• NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
• OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 4
• 241000700159 Rattus Species 0.000 description 4
• KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 4
• QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
• 125000002947 alkylene group Chemical group 0.000 description 4
• 150000001412 amines Chemical class 0.000 description 4
• 125000000732 arylene group Chemical group 0.000 description 4
• UORVGPXVDQYIDP-UHFFFAOYSA-N borane Chemical compound B UORVGPXVDQYIDP-UHFFFAOYSA-N 0.000 description 4
• 125000001246 bromo group Chemical group Br* 0.000 description 4
• 210000003169 central nervous system Anatomy 0.000 description 4
• 239000003795 chemical substances by application Substances 0.000 description 4
• ZPUCINDJVBIVPJ-LJISPDSOSA-N cocaine Chemical compound O([C@H]1C[C@@H]2CC[C@@H](N2C)[C@H]1C(=O)OC)C(=O)C1=CC=CC=C1 ZPUCINDJVBIVPJ-LJISPDSOSA-N 0.000 description 4
• 239000000706 filtrate Substances 0.000 description 4
• 125000002887 hydroxy group Chemical group [H]O* 0.000 description 4
• 238000002347 injection Methods 0.000 description 4
• 239000007924 injection Substances 0.000 description 4
• 239000007937 lozenge Substances 0.000 description 4
• 239000000463 material Substances 0.000 description 4
• 238000005259 measurement Methods 0.000 description 4
• 239000012528 membrane Substances 0.000 description 4
• 239000007922 nasal spray Substances 0.000 description 4
• 229940097496 nasal spray Drugs 0.000 description 4
• 239000003921 oil Substances 0.000 description 4
• 235000019198 oils Nutrition 0.000 description 4
• 229910052763 palladium Inorganic materials 0.000 description 4
• BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 4
• 239000000047 product Substances 0.000 description 4
• UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 4
• 239000012312 sodium hydride Substances 0.000 description 4
• 229910000104 sodium hydride Inorganic materials 0.000 description 4
• 239000003381 stabilizer Substances 0.000 description 4
• NVBFHJWHLNUMCV-UHFFFAOYSA-N sulfamide Chemical compound NS(N)(=O)=O NVBFHJWHLNUMCV-UHFFFAOYSA-N 0.000 description 4
• 239000000375 suspending agent Substances 0.000 description 4
• 238000013268 sustained release Methods 0.000 description 4
• JRBRVPRCINZXEB-UHFFFAOYSA-N tert-butyl 4-(3-amino-2-cyanophenyl)piperazine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCN1C1=CC=CC(N)=C1C#N JRBRVPRCINZXEB-UHFFFAOYSA-N 0.000 description 4
• JHLVEBNWCCKSGY-UHFFFAOYSA-N tert-butyl n-methylcarbamate Chemical compound CNC(=O)OC(C)(C)C JHLVEBNWCCKSGY-UHFFFAOYSA-N 0.000 description 4
• 239000002562 thickening agent Substances 0.000 description 4
• 229910052727 yttrium Inorganic materials 0.000 description 4
• OGWBVTDYXWQJSM-UHFFFAOYSA-N (2-amino-6-bromophenyl)methanol Chemical compound NC1=CC=CC(Br)=C1CO OGWBVTDYXWQJSM-UHFFFAOYSA-N 0.000 description 3
• HHWLXBAFBRSXCQ-UHFFFAOYSA-N (2-bromo-6-nitrophenyl)methyl acetate Chemical compound CC(=O)OCC1=C(Br)C=CC=C1[N+]([O-])=O HHWLXBAFBRSXCQ-UHFFFAOYSA-N 0.000 description 3
• ZYDGHQSJZAFMLU-UHFFFAOYSA-N 2,6-dinitrobenzonitrile Chemical compound [O-][N+](=O)C1=CC=CC([N+]([O-])=O)=C1C#N ZYDGHQSJZAFMLU-UHFFFAOYSA-N 0.000 description 3
• ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
• JSXJYGLDJJHAPT-UHFFFAOYSA-N 2-chloro-5-fluoro-1,3-dinitrobenzene Chemical compound [O-][N+](=O)C1=CC(F)=CC([N+]([O-])=O)=C1Cl JSXJYGLDJJHAPT-UHFFFAOYSA-N 0.000 description 3
• XZVJGIWTWBRGBL-UHFFFAOYSA-N 5-bromo-1,4-dihydro-3,1-benzoxazin-2-one Chemical compound N1C(=O)OCC2=C1C=CC=C2Br XZVJGIWTWBRGBL-UHFFFAOYSA-N 0.000 description 3
• 244000215068 Acacia senegal Species 0.000 description 3
• WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
• 239000004342 Benzoyl peroxide Substances 0.000 description 3
• OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 3
• CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 3
• QMMFVYPAHWMCMS-UHFFFAOYSA-N Dimethyl sulfide Chemical compound CSC QMMFVYPAHWMCMS-UHFFFAOYSA-N 0.000 description 3
• 108010010803 Gelatin Proteins 0.000 description 3
• 229920000084 Gum arabic Polymers 0.000 description 3
• 239000007868 Raney catalyst Substances 0.000 description 3
• NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 3
• 229910000564 Raney nickel Inorganic materials 0.000 description 3
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
• HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
• 229930006000 Sucrose Natural products 0.000 description 3
• CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
• NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 3
• 235000010489 acacia gum Nutrition 0.000 description 3
• 239000000205 acacia gum Substances 0.000 description 3
• 235000011054 acetic acid Nutrition 0.000 description 3
• DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 3
• 239000005557 antagonist Substances 0.000 description 3
• 239000007900 aqueous suspension Substances 0.000 description 3
• 125000003710 aryl alkyl group Chemical group 0.000 description 3
• 235000019400 benzoyl peroxide Nutrition 0.000 description 3
• 125000001743 benzylic group Chemical group 0.000 description 3
• MUALRAIOVNYAIW-UHFFFAOYSA-N binap Chemical compound C1=CC=CC=C1P(C=1C(=C2C=CC=CC2=CC=1)C=1C2=CC=CC=C2C=CC=1P(C=1C=CC=CC=1)C=1C=CC=CC=1)C1=CC=CC=C1 MUALRAIOVNYAIW-UHFFFAOYSA-N 0.000 description 3
• 210000004556 brain Anatomy 0.000 description 3
• 239000001768 carboxy methyl cellulose Substances 0.000 description 3
• 239000000969 carrier Substances 0.000 description 3
• 239000003054 catalyst Substances 0.000 description 3
• 230000001149 cognitive effect Effects 0.000 description 3
• 239000003086 colorant Substances 0.000 description 3
• 238000001816 cooling Methods 0.000 description 3
• 239000006071 cream Substances 0.000 description 3
• 125000004663 dialkyl amino group Chemical group 0.000 description 3
• 239000003085 diluting agent Substances 0.000 description 3
• 239000002270 dispersing agent Substances 0.000 description 3
• 230000000694 effects Effects 0.000 description 3
• 239000003995 emulsifying agent Substances 0.000 description 3
• 239000008273 gelatin Substances 0.000 description 3
• 229920000159 gelatin Polymers 0.000 description 3
• 235000019322 gelatine Nutrition 0.000 description 3
• 235000011852 gelatine desserts Nutrition 0.000 description 3
• 150000004820 halides Chemical class 0.000 description 3
• 229910052736 halogen Inorganic materials 0.000 description 3
• 150000002367 halogens Chemical class 0.000 description 3
• 125000005842 heteroatom Chemical group 0.000 description 3
• 238000000338 in vitro Methods 0.000 description 3
• 238000001727 in vivo Methods 0.000 description 3
• 238000001802 infusion Methods 0.000 description 3
• 239000002480 mineral oil Substances 0.000 description 3
• 235000010446 mineral oil Nutrition 0.000 description 3
• 125000003884 phenylalkyl group Chemical group 0.000 description 3
• SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 3
• 238000012746 preparative thin layer chromatography Methods 0.000 description 3
• 239000003755 preservative agent Substances 0.000 description 3
• 125000004076 pyridyl group Chemical group 0.000 description 3
• 125000006413 ring segment Chemical group 0.000 description 3
• 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 3
• 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 3
• 239000007921 spray Substances 0.000 description 3
• 238000007920 subcutaneous administration Methods 0.000 description 3
• 239000000126 substance Substances 0.000 description 3
• 239000005720 sucrose Substances 0.000 description 3
• 150000003456 sulfonamides Chemical class 0.000 description 3
• 239000011593 sulfur Substances 0.000 description 3
• 239000000829 suppository Substances 0.000 description 3
• 239000012730 sustained-release form Substances 0.000 description 3
• PAZQYBNHAGRNGA-UHFFFAOYSA-N tert-butyl 4-(2-cyano-3,6-difluorophenyl)piperazine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCN1C1=C(F)C=CC(F)=C1C#N PAZQYBNHAGRNGA-UHFFFAOYSA-N 0.000 description 3
• XKXYIEJKQOOKRM-UHFFFAOYSA-N tert-butyl 4-(2-cyano-3-nitrophenyl)piperazine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCN1C1=CC=CC([N+]([O-])=O)=C1C#N XKXYIEJKQOOKRM-UHFFFAOYSA-N 0.000 description 3
• FIKWWOMVLIDGFS-UHFFFAOYSA-N tert-butyl 4-(2-cyano-5-methoxy-3-nitrophenyl)piperazine-1-carboxylate Chemical compound [O-][N+](=O)C1=CC(OC)=CC(N2CCN(CC2)C(=O)OC(C)(C)C)=C1C#N FIKWWOMVLIDGFS-UHFFFAOYSA-N 0.000 description 3
• PQZHTTHMBDTHTB-UHFFFAOYSA-N tert-butyl 4-(2-oxo-1,4-dihydro-3,1-benzoxazin-5-yl)piperazine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCN1C1=CC=CC2=C1COC(=O)N2 PQZHTTHMBDTHTB-UHFFFAOYSA-N 0.000 description 3
• DVYDXWVJJYYMRL-UHFFFAOYSA-N tert-butyl 4-(3-benzamido-2-cyano-5-methoxyphenyl)piperazine-1-carboxylate Chemical compound N#CC=1C(N2CCN(CC2)C(=O)OC(C)(C)C)=CC(OC)=CC=1NC(=O)C1=CC=CC=C1 DVYDXWVJJYYMRL-UHFFFAOYSA-N 0.000 description 3
• MIUPDFJHPJHLAI-UHFFFAOYSA-N tert-butyl 4-[3-(benzylamino)-2-cyano-6-fluorophenyl]piperazine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCN1C1=C(F)C=CC(NCC=2C=CC=CC=2)=C1C#N MIUPDFJHPJHLAI-UHFFFAOYSA-N 0.000 description 3
• 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 3
• JBJXIXKCVYWJDD-UHFFFAOYSA-N tert-butyl n-[(2-amino-6-bromophenyl)methyl]-n-methylcarbamate Chemical compound CC(C)(C)OC(=O)N(C)CC1=C(N)C=CC=C1Br JBJXIXKCVYWJDD-UHFFFAOYSA-N 0.000 description 3
• VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 3
• SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 2
• QLLXWADSIGOEQZ-UHFFFAOYSA-N (2-bromo-6-nitrophenyl)methanol Chemical compound OCC1=C(Br)C=CC=C1[N+]([O-])=O QLLXWADSIGOEQZ-UHFFFAOYSA-N 0.000 description 2
• QDCVTDWUEQSWLR-UHFFFAOYSA-N 1-[(2-methylphenyl)methyl]-5-piperazin-1-yl-3,4-dihydroquinazolin-2-one;hydrochloride Chemical compound Cl.CC1=CC=CC=C1CN1C2=CC=CC(N3CCNCC3)=C2CNC1=O QDCVTDWUEQSWLR-UHFFFAOYSA-N 0.000 description 2
• OMFGIEOAFDCZLM-UHFFFAOYSA-N 1-benzyl-5-bromo-3-methyl-4h-2$l^{6},1,3-benzothiadiazine 2,2-dioxide Chemical compound O=S1(=O)N(C)CC2=C(Br)C=CC=C2N1CC1=CC=CC=C1 OMFGIEOAFDCZLM-UHFFFAOYSA-N 0.000 description 2
• IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 2
• HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
• QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
• VVLXEASYKMQILM-UHFFFAOYSA-N 3-amino-2-nitrobenzonitrile Chemical compound NC1=CC=CC(C#N)=C1[N+]([O-])=O VVLXEASYKMQILM-UHFFFAOYSA-N 0.000 description 2
• 125000006284 3-fluorobenzyl group Chemical group [H]C1=C([H])C(=C([H])C(F)=C1[H])C([H])([H])* 0.000 description 2
• HQQTZCPKNZVLFF-UHFFFAOYSA-N 4h-1,2-benzoxazin-3-one Chemical class C1=CC=C2ONC(=O)CC2=C1 HQQTZCPKNZVLFF-UHFFFAOYSA-N 0.000 description 2
• ZMGMDXCADSRNCX-UHFFFAOYSA-N 5,6-dihydroxy-1,3-diazepan-2-one Chemical compound OC1CNC(=O)NCC1O ZMGMDXCADSRNCX-UHFFFAOYSA-N 0.000 description 2
• NXFTUJQLWIVIDL-UHFFFAOYSA-N 5-bromo-1-[(3-fluorophenyl)methyl]-3-methyl-4h-quinazolin-2-one Chemical compound O=C1N(C)CC2=C(Br)C=CC=C2N1CC1=CC=CC(F)=C1 NXFTUJQLWIVIDL-UHFFFAOYSA-N 0.000 description 2
• IVGUUMKLOOVRLN-UHFFFAOYSA-N 5-bromo-3-methyl-1,4-dihydro-2$l^{6},1,3-benzothiadiazine 2,2-dioxide Chemical compound C1=CC=C2NS(=O)(=O)N(C)CC2=C1Br IVGUUMKLOOVRLN-UHFFFAOYSA-N 0.000 description 2
• SZMUQIIVLVKCCL-UHFFFAOYSA-N 5-bromo-3-methyl-1,4-dihydroquinazolin-2-one Chemical compound C1=CC=C2NC(=O)N(C)CC2=C1Br SZMUQIIVLVKCCL-UHFFFAOYSA-N 0.000 description 2
• 102100036321 5-hydroxytryptamine receptor 2A Human genes 0.000 description 2
• 101710138091 5-hydroxytryptamine receptor 2A Proteins 0.000 description 2
• DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 2
• 208000019901 Anxiety disease Diseases 0.000 description 2
• CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
• 241000416162 Astragalus gummifer Species 0.000 description 2
• WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 2
• 208000032841 Bulimia Diseases 0.000 description 2
• 206010006550 Bulimia nervosa Diseases 0.000 description 2
• HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
• RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
• FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 2
• 208000030814 Eating disease Diseases 0.000 description 2
• 208000027534 Emotional disease Diseases 0.000 description 2
• 208000019454 Feeding and Eating disease Diseases 0.000 description 2
• VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
• PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
• AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
• 206010019196 Head injury Diseases 0.000 description 2
• KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
• GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
• 241001465754 Metazoa Species 0.000 description 2
• BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 2
• 208000019695 Migraine disease Diseases 0.000 description 2
• MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 2
• 208000008589 Obesity Diseases 0.000 description 2
• 208000021384 Obsessive-Compulsive disease Diseases 0.000 description 2
• 206010033664 Panic attack Diseases 0.000 description 2
• XYFCBTPGUUZFHI-UHFFFAOYSA-N Phosphine Chemical compound P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 description 2
• GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 2
• 239000002202 Polyethylene glycol Substances 0.000 description 2
• CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
• WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 2
• 229920002472 Starch Polymers 0.000 description 2
• FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 2
• DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 2
• 229920001615 Tragacanth Polymers 0.000 description 2
• 230000009471 action Effects 0.000 description 2
• 239000013543 active substance Substances 0.000 description 2
• 239000000443 aerosol Substances 0.000 description 2
• 239000000556 agonist Substances 0.000 description 2
• 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
• 208000022531 anorexia Diseases 0.000 description 2
• 230000036506 anxiety Effects 0.000 description 2
• 239000007864 aqueous solution Substances 0.000 description 2
• 150000001502 aryl halides Chemical class 0.000 description 2
• 235000010323 ascorbic acid Nutrition 0.000 description 2
• 229960005070 ascorbic acid Drugs 0.000 description 2
• 239000011668 ascorbic acid Substances 0.000 description 2
• 239000012131 assay buffer Substances 0.000 description 2
• 125000002785 azepinyl group Chemical group 0.000 description 2
• 229940049706 benzodiazepine Drugs 0.000 description 2
• 125000003310 benzodiazepinyl group Chemical class N1N=C(C=CC2=C1C=CC=C2)* 0.000 description 2
• WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
• 125000004619 benzopyranyl group Chemical group O1C(C=CC2=C1C=CC=C2)* 0.000 description 2
• DZBUGLKDJFMEHC-UHFFFAOYSA-N benzoquinolinylidene Natural products C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 2
• 125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 description 2
• PASDCCFISLVPSO-UHFFFAOYSA-N benzoyl chloride Chemical compound ClC(=O)C1=CC=CC=C1 PASDCCFISLVPSO-UHFFFAOYSA-N 0.000 description 2
• AGEZXYOZHKGVCM-UHFFFAOYSA-N benzyl bromide Chemical compound BrCC1=CC=CC=C1 AGEZXYOZHKGVCM-UHFFFAOYSA-N 0.000 description 2
• 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 2
• NHOWLEZFTHYCTP-UHFFFAOYSA-N benzylhydrazine Chemical compound NNCC1=CC=CC=C1 NHOWLEZFTHYCTP-UHFFFAOYSA-N 0.000 description 2
• 125000002619 bicyclic group Chemical group 0.000 description 2
• 229910000085 borane Inorganic materials 0.000 description 2
• GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 2
• 229910052794 bromium Inorganic materials 0.000 description 2
• 230000003197 catalytic effect Effects 0.000 description 2
• 210000000170 cell membrane Anatomy 0.000 description 2
• 239000003638 chemical reducing agent Substances 0.000 description 2
• 229960003920 cocaine Drugs 0.000 description 2
• 229940110456 cocoa butter Drugs 0.000 description 2
• 235000019868 cocoa butter Nutrition 0.000 description 2
• 230000037410 cognitive enhancement Effects 0.000 description 2
• 238000006880 cross-coupling reaction Methods 0.000 description 2
• 206010061428 decreased appetite Diseases 0.000 description 2
• ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 2
• 235000014632 disordered eating Nutrition 0.000 description 2
• 229940079593 drug Drugs 0.000 description 2
• 230000009977 dual effect Effects 0.000 description 2
• 206010015037 epilepsy Diseases 0.000 description 2
• 150000002148 esters Chemical class 0.000 description 2
• 238000002474 experimental method Methods 0.000 description 2
• 239000000796 flavoring agent Substances 0.000 description 2
• 239000000499 gel Substances 0.000 description 2
• 230000036541 health Effects 0.000 description 2
• 238000010438 heat treatment Methods 0.000 description 2
• 208000003906 hydrocephalus Diseases 0.000 description 2
• 239000012442 inert solvent Substances 0.000 description 2
• 208000014674 injury Diseases 0.000 description 2
• SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 2
• TYQCGQRIZGCHNB-JLAZNSOCSA-N l-ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(O)=C(O)C1=O TYQCGQRIZGCHNB-JLAZNSOCSA-N 0.000 description 2
• JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
• 239000008101 lactose Substances 0.000 description 2
• 239000000787 lecithin Substances 0.000 description 2
• 235000010445 lecithin Nutrition 0.000 description 2
• 229940067606 lecithin Drugs 0.000 description 2
• 244000144972 livestock Species 0.000 description 2
• 239000006210 lotion Substances 0.000 description 2
• HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
• VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 2
• 239000011976 maleic acid Substances 0.000 description 2
• 229940098779 methanesulfonic acid Drugs 0.000 description 2
• BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
• 229920000609 methyl cellulose Polymers 0.000 description 2
• 239000001923 methylcellulose Substances 0.000 description 2
• 235000010981 methylcellulose Nutrition 0.000 description 2
• 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 2
• 206010027599 migraine Diseases 0.000 description 2
• 125000002950 monocyclic group Chemical group 0.000 description 2
• TXXHDPDFNKHHGW-UHFFFAOYSA-N muconic acid Chemical compound OC(=O)C=CC=CC(O)=O TXXHDPDFNKHHGW-UHFFFAOYSA-N 0.000 description 2
• HHQJWDKIRXRTLS-UHFFFAOYSA-N n'-bromobutanediamide Chemical compound NC(=O)CCC(=O)NBr HHQJWDKIRXRTLS-UHFFFAOYSA-N 0.000 description 2
• SYSQUGFVNFXIIT-UHFFFAOYSA-N n-[4-(1,3-benzoxazol-2-yl)phenyl]-4-nitrobenzenesulfonamide Chemical class C1=CC([N+](=O)[O-])=CC=C1S(=O)(=O)NC1=CC=C(C=2OC3=CC=CC=C3N=2)C=C1 SYSQUGFVNFXIIT-UHFFFAOYSA-N 0.000 description 2
• FJCCWUVWFDOSAU-UHFFFAOYSA-N n-benzylnitramide Chemical compound [O-][N+](=O)NCC1=CC=CC=C1 FJCCWUVWFDOSAU-UHFFFAOYSA-N 0.000 description 2
• 210000003928 nasal cavity Anatomy 0.000 description 2
• 239000006199 nebulizer Substances 0.000 description 2
• PXHVJJICTQNCMI-UHFFFAOYSA-N nickel Substances [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
• 229960002715 nicotine Drugs 0.000 description 2
• SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 2
• 125000004433 nitrogen atom Chemical group N* 0.000 description 2
• 239000012454 non-polar solvent Substances 0.000 description 2
• 235000020824 obesity Nutrition 0.000 description 2
• 239000002674 ointment Substances 0.000 description 2
• 208000019906 panic disease Diseases 0.000 description 2
• 239000002245 particle Substances 0.000 description 2
• 125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 description 2
• 239000006187 pill Substances 0.000 description 2
• 125000004193 piperazinyl group Chemical group 0.000 description 2
• XUWHAWMETYGRKB-UHFFFAOYSA-N piperidin-2-one Chemical compound O=C1CCCCN1 XUWHAWMETYGRKB-UHFFFAOYSA-N 0.000 description 2
• BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
• 229920001223 polyethylene glycol Polymers 0.000 description 2
• 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
• 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
• 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
• 229910000027 potassium carbonate Inorganic materials 0.000 description 2
• 125000000714 pyrimidinyl group Chemical group 0.000 description 2
• LISFMEBWQUVKPJ-UHFFFAOYSA-N quinolin-2-ol Chemical class C1=CC=C2NC(=O)C=CC2=C1 LISFMEBWQUVKPJ-UHFFFAOYSA-N 0.000 description 2
• YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
• 208000019116 sleep disease Diseases 0.000 description 2
• 239000011780 sodium chloride Substances 0.000 description 2
• MFRIHAYPQRLWNB-UHFFFAOYSA-N sodium tert-butoxide Chemical compound [Na+].CC(C)(C)[O-] MFRIHAYPQRLWNB-UHFFFAOYSA-N 0.000 description 2
• 230000009870 specific binding Effects 0.000 description 2
• 210000000278 spinal cord Anatomy 0.000 description 2
• 239000008107 starch Substances 0.000 description 2
• 235000019698 starch Nutrition 0.000 description 2
• 239000007858 starting material Substances 0.000 description 2
• 238000006467 substitution reaction Methods 0.000 description 2
• YBBRCQOCSYXUOC-UHFFFAOYSA-N sulfuryl dichloride Chemical compound ClS(Cl)(=O)=O YBBRCQOCSYXUOC-UHFFFAOYSA-N 0.000 description 2
• 239000011975 tartaric acid Substances 0.000 description 2
• 235000002906 tartaric acid Nutrition 0.000 description 2
• DYHSDKLCOJIUFX-UHFFFAOYSA-N tert-butoxycarbonyl anhydride Chemical compound CC(C)(C)OC(=O)OC(=O)OC(C)(C)C DYHSDKLCOJIUFX-UHFFFAOYSA-N 0.000 description 2
• SOHKJZAWOLIKCI-UHFFFAOYSA-N tert-butyl 4-(1-benzyl-6-fluoro-2-oxo-3,4-dihydroquinazolin-5-yl)piperazine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCN1C1=C(F)C=CC2=C1CNC(=O)N2CC1=CC=CC=C1 SOHKJZAWOLIKCI-UHFFFAOYSA-N 0.000 description 2
• KZEAPECIYZRMSE-UHFFFAOYSA-N tert-butyl 4-[1-[(3-fluorophenyl)methyl]-7-methoxy-2-oxo-3,4-dihydroquinazolin-5-yl]piperazine-1-carboxylate Chemical compound C=12CNC(=O)N(CC=3C=C(F)C=CC=3)C2=CC(OC)=CC=1N1CCN(C(=O)OC(C)(C)C)CC1 KZEAPECIYZRMSE-UHFFFAOYSA-N 0.000 description 2
• WPIHHKXYCISOFU-UHFFFAOYSA-N tert-butyl 4-[2-(aminomethyl)-3-(benzylamino)-5-methoxyphenyl]piperazine-1-carboxylate Chemical compound NCC=1C(N2CCN(CC2)C(=O)OC(C)(C)C)=CC(OC)=CC=1NCC1=CC=CC=C1 WPIHHKXYCISOFU-UHFFFAOYSA-N 0.000 description 2
• SXCYZPBKFOMTJB-UHFFFAOYSA-N tert-butyl 4-[2-(aminomethyl)-3-(benzylamino)-6-fluorophenyl]piperazine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCN1C1=C(F)C=CC(NCC=2C=CC=CC=2)=C1CN SXCYZPBKFOMTJB-UHFFFAOYSA-N 0.000 description 2
• SKTVPIYLGOZNFH-UHFFFAOYSA-N tert-butyl 4-[2-(aminomethyl)-3-(benzylamino)phenyl]piperazine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCN1C1=CC=CC(NCC=2C=CC=CC=2)=C1CN SKTVPIYLGOZNFH-UHFFFAOYSA-N 0.000 description 2
• RDYZQAPSLFBYQZ-UHFFFAOYSA-N tert-butyl 4-[2-(aminomethyl)-3-[(4-fluorophenyl)methylamino]phenyl]piperazine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCN1C1=CC=CC(NCC=2C=CC(F)=CC=2)=C1CN RDYZQAPSLFBYQZ-UHFFFAOYSA-N 0.000 description 2
• ZSQVTGRXKPWHQD-UHFFFAOYSA-N tert-butyl 4-[2-cyano-3-[(2-fluorobenzoyl)amino]phenyl]piperazine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCN1C1=CC=CC(NC(=O)C=2C(=CC=CC=2)F)=C1C#N ZSQVTGRXKPWHQD-UHFFFAOYSA-N 0.000 description 2
• RDJSMZOMBDWYRJ-UHFFFAOYSA-N tert-butyl n-[(2-bromo-6-nitrophenyl)methyl]-n-methylcarbamate Chemical compound CC(C)(C)OC(=O)N(C)CC1=C(Br)C=CC=C1[N+]([O-])=O RDJSMZOMBDWYRJ-UHFFFAOYSA-N 0.000 description 2
• 125000001544 thienyl group Chemical group 0.000 description 2
• 125000003396 thiol group Chemical group [H]S* 0.000 description 2
• FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
• JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
• 238000011200 topical administration Methods 0.000 description 2
• 235000010487 tragacanth Nutrition 0.000 description 2
• 239000000196 tragacanth Substances 0.000 description 2
• 229940116362 tragacanth Drugs 0.000 description 2
• 230000008733 trauma Effects 0.000 description 2
• LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
• 229910052720 vanadium Inorganic materials 0.000 description 2
• 239000003981 vehicle Substances 0.000 description 2
• 239000008215 water for injection Substances 0.000 description 2
• XYSVLPYRVUUCGA-UHFFFAOYSA-N (2-bromo-6-nitrophenyl)methyl-methylcarbamic acid Chemical compound OC(=O)N(C)CC1=C(Br)C=CC=C1[N+]([O-])=O XYSVLPYRVUUCGA-UHFFFAOYSA-N 0.000 description 1
• QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical compound O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 description 1
• IIDFCIIZUMOXFE-UHFFFAOYSA-N (4-fluorophenyl)-(1-hydroxypiperidin-4-yl)methanone Chemical compound C1CN(O)CCC1C(=O)C1=CC=C(F)C=C1 IIDFCIIZUMOXFE-UHFFFAOYSA-N 0.000 description 1
• MIOPJNTWMNEORI-GMSGAONNSA-N (S)-camphorsulfonic acid Chemical compound C1C[C@@]2(CS(O)(=O)=O)C(=O)C[C@@H]1C2(C)C MIOPJNTWMNEORI-GMSGAONNSA-N 0.000 description 1
• BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
• SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 1
• ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 1
• DDMOUSALMHHKOS-UHFFFAOYSA-N 1,2-dichloro-1,1,2,2-tetrafluoroethane Chemical compound FC(F)(Cl)C(F)(F)Cl DDMOUSALMHHKOS-UHFFFAOYSA-N 0.000 description 1
• 125000002030 1,2-phenylene group Chemical group [H]C1=C([H])C([*:1])=C([*:2])C([H])=C1[H] 0.000 description 1
• 125000001989 1,3-phenylene group Chemical group [H]C1=C([H])C([*:1])=C([H])C([*:2])=C1[H] 0.000 description 1
• RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
• 125000001140 1,4-phenylene group Chemical group [H]C1=C([H])C([*:2])=C([H])C([H])=C1[*:1] 0.000 description 1
• SCBZBMXPJYMXRC-UHFFFAOYSA-N 1-(bromomethyl)-3-fluorobenzene Chemical compound FC1=CC=CC(CBr)=C1 SCBZBMXPJYMXRC-UHFFFAOYSA-N 0.000 description 1
• PVOAHINGSUIXLS-UHFFFAOYSA-N 1-Methylpiperazine Chemical compound CN1CCNCC1 PVOAHINGSUIXLS-UHFFFAOYSA-N 0.000 description 1
• LAGWPXIROMCTLU-UHFFFAOYSA-N 1-[(2,3-dichlorophenyl)methyl]-5-piperazin-1-yl-3,4-dihydro-2$l^{6},1,3-benzothiadiazine 2,2-dioxide;hydrochloride Chemical compound Cl.ClC1=CC=CC(CN2S(NCC3=C(N4CCNCC4)C=CC=C32)(=O)=O)=C1Cl LAGWPXIROMCTLU-UHFFFAOYSA-N 0.000 description 1
• KLNXTPUKVOESSQ-UHFFFAOYSA-N 1-[(2,3-dichlorophenyl)methyl]-5-piperazin-1-yl-3,4-dihydroquinazolin-2-one;hydrochloride Chemical compound Cl.ClC1=CC=CC(CN2C3=CC=CC(=C3CNC2=O)N2CCNCC2)=C1Cl KLNXTPUKVOESSQ-UHFFFAOYSA-N 0.000 description 1
• AIHNFKNGFHMIBL-UHFFFAOYSA-N 1-[(2,3-difluorophenyl)methyl]-5-piperazin-1-yl-3,4-dihydro-2$l^{6},1,3-benzothiadiazine 2,2-dioxide;hydrochloride Chemical compound Cl.FC1=CC=CC(CN2S(NCC3=C(N4CCNCC4)C=CC=C32)(=O)=O)=C1F AIHNFKNGFHMIBL-UHFFFAOYSA-N 0.000 description 1
• ANCZFVRHHVBUOD-UHFFFAOYSA-N 1-[(2,3-difluorophenyl)methyl]-5-piperazin-1-yl-3,4-dihydroquinazolin-2-one;hydrochloride Chemical compound Cl.FC1=CC=CC(CN2C3=CC=CC(=C3CNC2=O)N2CCNCC2)=C1F ANCZFVRHHVBUOD-UHFFFAOYSA-N 0.000 description 1
• DADWGVMFHOFPQO-UHFFFAOYSA-N 1-[(2,3-difluorophenyl)methyl]-5-piperazin-1-yl-3-propan-2-yl-4h-quinazolin-2-one;hydrochloride Chemical compound Cl.O=C1N(C(C)C)CC2=C(N3CCNCC3)C=CC=C2N1CC1=CC=CC(F)=C1F DADWGVMFHOFPQO-UHFFFAOYSA-N 0.000 description 1
• UVAZZBIYVJZBOO-UHFFFAOYSA-N 1-[(2-chlorophenyl)methyl]-5-piperazin-1-yl-3,4-dihydro-2$l^{6},1,3-benzothiadiazine 2,2-dioxide;hydrochloride Chemical compound Cl.ClC1=CC=CC=C1CN1S(=O)(=O)NCC2=C(N3CCNCC3)C=CC=C21 UVAZZBIYVJZBOO-UHFFFAOYSA-N 0.000 description 1
• IMOLSGLELCZXQC-UHFFFAOYSA-N 1-[(2-chlorophenyl)methyl]-5-piperazin-1-yl-3,4-dihydroquinazolin-2-one;hydrochloride Chemical compound Cl.ClC1=CC=CC=C1CN1C2=CC=CC(N3CCNCC3)=C2CNC1=O IMOLSGLELCZXQC-UHFFFAOYSA-N 0.000 description 1
• YXDXXKKZLXJSCH-UHFFFAOYSA-N 1-[(2-fluorophenyl)methyl]-3-methyl-5-piperazin-1-yl-4h-quinazolin-2-one;hydrochloride Chemical compound Cl.O=C1N(C)CC2=C(N3CCNCC3)C=CC=C2N1CC1=CC=CC=C1F YXDXXKKZLXJSCH-UHFFFAOYSA-N 0.000 description 1
• MBKOSWMLPNRORB-UHFFFAOYSA-N 1-[(2-fluorophenyl)methyl]-5-piperazin-1-yl-3,4-dihydro-2$l^{6},1,3-benzothiadiazine 2,2-dioxide;hydrochloride Chemical compound Cl.FC1=CC=CC=C1CN1S(=O)(=O)NCC2=C(N3CCNCC3)C=CC=C21 MBKOSWMLPNRORB-UHFFFAOYSA-N 0.000 description 1
• NYJRAVILJYKZOY-UHFFFAOYSA-N 1-[(2-fluorophenyl)methyl]-5-piperazin-1-yl-3,4-dihydroquinazolin-2-one;hydrochloride Chemical compound Cl.FC1=CC=CC=C1CN1C2=CC=CC(N3CCNCC3)=C2CNC1=O NYJRAVILJYKZOY-UHFFFAOYSA-N 0.000 description 1
• ANWFYPFYFUAZBE-UHFFFAOYSA-N 1-[(2-fluorophenyl)methyl]-5-piperazin-1-yl-3-propan-2-yl-4h-quinazolin-2-one;hydrochloride Chemical compound Cl.O=C1N(C(C)C)CC2=C(N3CCNCC3)C=CC=C2N1CC1=CC=CC=C1F ANWFYPFYFUAZBE-UHFFFAOYSA-N 0.000 description 1
• KHMMILIEUWOQLI-UHFFFAOYSA-N 1-[(2-fluorophenyl)methyl]-5-piperazin-1-yl-4h-3,1-benzoxazin-2-one;hydrochloride Chemical compound Cl.FC1=CC=CC=C1CN1C2=CC=CC(N3CCNCC3)=C2COC1=O KHMMILIEUWOQLI-UHFFFAOYSA-N 0.000 description 1
• IYMXNGUGXSUJIM-UHFFFAOYSA-N 1-[(2-methylphenyl)methyl]-5-piperazin-1-yl-3,4-dihydro-2$l^{6},1,3-benzothiadiazine 2,2-dioxide;hydrochloride Chemical compound Cl.CC1=CC=CC=C1CN1S(=O)(=O)NCC2=C(N3CCNCC3)C=CC=C21 IYMXNGUGXSUJIM-UHFFFAOYSA-N 0.000 description 1
• VZWASGNXRGWZQY-UHFFFAOYSA-N 1-[(3,4-dichlorophenyl)methyl]-5-piperazin-1-yl-3,4-dihydro-2$l^{6},1,3-benzothiadiazine 2,2-dioxide;hydrochloride Chemical compound Cl.C1=C(Cl)C(Cl)=CC=C1CN1S(=O)(=O)NCC2=C(N3CCNCC3)C=CC=C21 VZWASGNXRGWZQY-UHFFFAOYSA-N 0.000 description 1
• AZUDHZANNZOZSC-UHFFFAOYSA-N 1-[(3,4-dichlorophenyl)methyl]-5-piperazin-1-yl-3,4-dihydroquinazolin-2-one;hydrochloride Chemical compound Cl.C1=C(Cl)C(Cl)=CC=C1CN1C2=CC=CC(N3CCNCC3)=C2CNC1=O AZUDHZANNZOZSC-UHFFFAOYSA-N 0.000 description 1
• GHCLQGKZJBAXJL-UHFFFAOYSA-N 1-[(3,4-difluorophenyl)methyl]-5-piperazin-1-yl-3,4-dihydro-2$l^{6},1,3-benzothiadiazine 2,2-dioxide;hydrochloride Chemical compound Cl.C1=C(F)C(F)=CC=C1CN1S(=O)(=O)NCC2=C(N3CCNCC3)C=CC=C21 GHCLQGKZJBAXJL-UHFFFAOYSA-N 0.000 description 1
• QLRTUDOJHVDNEG-UHFFFAOYSA-N 1-[(3,4-difluorophenyl)methyl]-5-piperazin-1-yl-3,4-dihydroquinazolin-2-one;hydrochloride Chemical compound Cl.C1=C(F)C(F)=CC=C1CN1C2=CC=CC(N3CCNCC3)=C2CNC1=O QLRTUDOJHVDNEG-UHFFFAOYSA-N 0.000 description 1
• ANBJJXDIXRMIJT-UHFFFAOYSA-N 1-[(3-chloro-2-fluorophenyl)methyl]-5-piperazin-1-yl-3,4-dihydro-2$l^{6},1,3-benzothiadiazine 2,2-dioxide;hydrochloride Chemical compound Cl.FC1=C(Cl)C=CC=C1CN1S(=O)(=O)NCC2=C(N3CCNCC3)C=CC=C21 ANBJJXDIXRMIJT-UHFFFAOYSA-N 0.000 description 1
• AFDHATVWAAGZLV-UHFFFAOYSA-N 1-[(3-chloro-2-fluorophenyl)methyl]-5-piperazin-1-yl-3,4-dihydroquinazolin-2-one;hydrochloride Chemical compound Cl.FC1=C(Cl)C=CC=C1CN1C2=CC=CC(N3CCNCC3)=C2CNC1=O AFDHATVWAAGZLV-UHFFFAOYSA-N 0.000 description 1
• XCVDSXAPWNHNFX-UHFFFAOYSA-N 1-[(3-chlorophenyl)methyl]-5-piperazin-1-yl-3,4-dihydro-2$l^{6},1,3-benzothiadiazine 2,2-dioxide;hydrochloride Chemical compound Cl.ClC1=CC=CC(CN2S(NCC3=C(N4CCNCC4)C=CC=C32)(=O)=O)=C1 XCVDSXAPWNHNFX-UHFFFAOYSA-N 0.000 description 1
• NOVLMGNBRQJTND-UHFFFAOYSA-N 1-[(3-chlorophenyl)methyl]-5-piperazin-1-yl-3,4-dihydroquinazolin-2-one;hydrochloride Chemical compound Cl.ClC1=CC=CC(CN2C3=CC=CC(=C3CNC2=O)N2CCNCC2)=C1 NOVLMGNBRQJTND-UHFFFAOYSA-N 0.000 description 1
• JVQFYMDCZJDTCB-UHFFFAOYSA-N 1-[(3-chlorophenyl)methyl]-5-piperazin-1-yl-3-propan-2-yl-4h-quinazolin-2-one;hydrochloride Chemical compound Cl.O=C1N(C(C)C)CC2=C(N3CCNCC3)C=CC=C2N1CC1=CC=CC(Cl)=C1 JVQFYMDCZJDTCB-UHFFFAOYSA-N 0.000 description 1
• LAKMZEUKEVUPPK-UHFFFAOYSA-N 1-[(3-fluorophenyl)methyl]-3-methyl-5-piperazin-1-yl-4h-quinazolin-2-one;hydrochloride Chemical compound Cl.O=C1N(C)CC2=C(N3CCNCC3)C=CC=C2N1CC1=CC=CC(F)=C1 LAKMZEUKEVUPPK-UHFFFAOYSA-N 0.000 description 1
• SYRPNZAAODTGPC-UHFFFAOYSA-N 1-[(3-fluorophenyl)methyl]-5-piperazin-1-yl-3,4-dihydro-2$l^{6},1,3-benzothiadiazine 2,2-dioxide;hydrochloride Chemical compound Cl.FC1=CC=CC(CN2S(NCC3=C(N4CCNCC4)C=CC=C32)(=O)=O)=C1 SYRPNZAAODTGPC-UHFFFAOYSA-N 0.000 description 1
• LXEQLGKPRHRRFG-UHFFFAOYSA-N 1-[(3-fluorophenyl)methyl]-5-piperazin-1-yl-3,4-dihydroquinazolin-2-one;hydrochloride Chemical compound Cl.FC1=CC=CC(CN2C3=CC=CC(=C3CNC2=O)N2CCNCC2)=C1 LXEQLGKPRHRRFG-UHFFFAOYSA-N 0.000 description 1
• RZXMNXLIQPHRBP-UHFFFAOYSA-N 1-[(3-fluorophenyl)methyl]-5-piperazin-1-yl-3-propan-2-yl-4h-quinazolin-2-one;hydrochloride Chemical compound Cl.O=C1N(C(C)C)CC2=C(N3CCNCC3)C=CC=C2N1CC1=CC=CC(F)=C1 RZXMNXLIQPHRBP-UHFFFAOYSA-N 0.000 description 1
• HEVNCXDTOJICPG-UHFFFAOYSA-N 1-[(3-fluorophenyl)methyl]-5-piperazin-1-yl-4h-3,1-benzoxazin-2-one;hydrochloride Chemical compound Cl.FC1=CC=CC(CN2C3=CC=CC(=C3COC2=O)N2CCNCC2)=C1 HEVNCXDTOJICPG-UHFFFAOYSA-N 0.000 description 1
• ZMKWEDUMRZVPFM-UHFFFAOYSA-N 1-[(4-chlorophenyl)methyl]-5-piperazin-1-yl-3,4-dihydro-2$l^{6},1,3-benzothiadiazine 2,2-dioxide;hydrochloride Chemical compound Cl.C1=CC(Cl)=CC=C1CN1S(=O)(=O)NCC2=C(N3CCNCC3)C=CC=C21 ZMKWEDUMRZVPFM-UHFFFAOYSA-N 0.000 description 1
• NRRQOAROMJOIJU-UHFFFAOYSA-N 1-[(4-chlorophenyl)methyl]-5-piperazin-1-yl-3,4-dihydroquinazolin-2-one;hydrochloride Chemical compound Cl.C1=CC(Cl)=CC=C1CN1C2=CC=CC(N3CCNCC3)=C2CNC1=O NRRQOAROMJOIJU-UHFFFAOYSA-N 0.000 description 1
• XAWIFRWFRRLDTH-UHFFFAOYSA-N 1-[(4-fluorophenyl)methyl]-3-methyl-5-piperazin-1-yl-4h-quinazolin-2-one;hydrochloride Chemical compound Cl.O=C1N(C)CC2=C(N3CCNCC3)C=CC=C2N1CC1=CC=C(F)C=C1 XAWIFRWFRRLDTH-UHFFFAOYSA-N 0.000 description 1
• HSBJJGMQQNCOGA-UHFFFAOYSA-N 1-[(4-fluorophenyl)methyl]-5-piperazin-1-yl-3,4-dihydro-2$l^{6},1,3-benzothiadiazine 2,2-dioxide;hydrochloride Chemical compound Cl.C1=CC(F)=CC=C1CN1S(=O)(=O)NCC2=C(N3CCNCC3)C=CC=C21 HSBJJGMQQNCOGA-UHFFFAOYSA-N 0.000 description 1
• XYICZDIMDKPBAI-UHFFFAOYSA-N 1-[(4-fluorophenyl)methyl]-5-piperazin-1-yl-3,4-dihydroquinazolin-2-one;hydrochloride Chemical compound Cl.C1=CC(F)=CC=C1CN1C2=CC=CC(N3CCNCC3)=C2CNC1=O XYICZDIMDKPBAI-UHFFFAOYSA-N 0.000 description 1
• DIAHKKRTPGLWCU-UHFFFAOYSA-N 1-[(4-fluorophenyl)methyl]-5-piperazin-1-yl-3-propan-2-yl-4h-quinazolin-2-one;hydrochloride Chemical compound Cl.O=C1N(C(C)C)CC2=C(N3CCNCC3)C=CC=C2N1CC1=CC=C(F)C=C1 DIAHKKRTPGLWCU-UHFFFAOYSA-N 0.000 description 1
• CJQBTUFJDLIUME-UHFFFAOYSA-N 1-benzyl-3-ethyl-5-piperazin-1-yl-4h-quinazolin-2-one;hydrochloride Chemical compound Cl.O=C1N(CC)CC2=C(N3CCNCC3)C=CC=C2N1CC1=CC=CC=C1 CJQBTUFJDLIUME-UHFFFAOYSA-N 0.000 description 1
• GKKFWORKTWBEOQ-UHFFFAOYSA-N 1-benzyl-3-methyl-5-piperazin-1-yl-4h-2$l^{6},1,3-benzothiadiazine 2,2-dioxide;hydrochloride Chemical compound Cl.O=S1(=O)N(C)CC2=C(N3CCNCC3)C=CC=C2N1CC1=CC=CC=C1 GKKFWORKTWBEOQ-UHFFFAOYSA-N 0.000 description 1
• LLJIIVFXHZNFQN-UHFFFAOYSA-N 1-benzyl-3-methyl-5-piperazin-1-yl-4h-quinazolin-2-one;hydrochloride Chemical compound Cl.O=C1N(C)CC2=C(N3CCNCC3)C=CC=C2N1CC1=CC=CC=C1 LLJIIVFXHZNFQN-UHFFFAOYSA-N 0.000 description 1
• WVWUNLWTQMXYFI-UHFFFAOYSA-N 1-benzyl-5-bromo-3-methyl-4h-quinazolin-2-one Chemical compound O=C1N(C)CC2=C(Br)C=CC=C2N1CC1=CC=CC=C1 WVWUNLWTQMXYFI-UHFFFAOYSA-N 0.000 description 1
• YSPOLXRMGVQQJY-UHFFFAOYSA-N 1-benzyl-5-piperazin-1-yl-3,4-dihydro-2$l^{6},1,3-benzothiadiazine 2,2-dioxide;hydrochloride Chemical compound Cl.O=S1(=O)NCC2=C(N3CCNCC3)C=CC=C2N1CC1=CC=CC=C1 YSPOLXRMGVQQJY-UHFFFAOYSA-N 0.000 description 1
• YOSDLMJJBVTWGY-UHFFFAOYSA-N 1-benzyl-5-piperazin-1-yl-3-propan-2-yl-4h-quinazolin-2-one;hydrochloride Chemical compound Cl.O=C1N(C(C)C)CC2=C(N3CCNCC3)C=CC=C2N1CC1=CC=CC=C1 YOSDLMJJBVTWGY-UHFFFAOYSA-N 0.000 description 1
• FCEZUAKIMWAKGE-UHFFFAOYSA-N 1-benzyl-5-piperazin-1-yl-4h-3,1-benzoxazin-2-one;hydrochloride Chemical compound Cl.O=C1OCC2=C(N3CCNCC3)C=CC=C2N1CC1=CC=CC=C1 FCEZUAKIMWAKGE-UHFFFAOYSA-N 0.000 description 1
• UZHZXMDNWIOKQB-UHFFFAOYSA-N 1-benzyl-6-fluoro-5-piperazin-1-yl-3,4-dihydroquinazolin-2-one;hydrochloride Chemical compound Cl.O=C1NCC2=C(N3CCNCC3)C(F)=CC=C2N1CC1=CC=CC=C1 UZHZXMDNWIOKQB-UHFFFAOYSA-N 0.000 description 1
• LYTNSGFSAXWBCA-UHFFFAOYSA-N 1-bromo-2-methyl-3-nitrobenzene Chemical compound CC1=C(Br)C=CC=C1[N+]([O-])=O LYTNSGFSAXWBCA-UHFFFAOYSA-N 0.000 description 1
• AXTGDCSMTYGJND-UHFFFAOYSA-N 1-dodecylazepan-2-one Chemical compound CCCCCCCCCCCCN1CCCCCC1=O AXTGDCSMTYGJND-UHFFFAOYSA-N 0.000 description 1
• ABEXEQSGABRUHS-UHFFFAOYSA-N 16-methylheptadecyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC(C)C ABEXEQSGABRUHS-UHFFFAOYSA-N 0.000 description 1
• YBYIRNPNPLQARY-UHFFFAOYSA-N 1H-indene Natural products C1=CC=C2CC=CC2=C1 YBYIRNPNPLQARY-UHFFFAOYSA-N 0.000 description 1
• YWTXHALVWAISPR-UHFFFAOYSA-N 2,3,6-trifluorobenzonitrile Chemical compound FC1=CC=C(F)C(C#N)=C1F YWTXHALVWAISPR-UHFFFAOYSA-N 0.000 description 1
• IFNWESYYDINUHV-UHFFFAOYSA-N 2,6-dimethylpiperazine Chemical compound CC1CNCC(C)N1 IFNWESYYDINUHV-UHFFFAOYSA-N 0.000 description 1
• NATAOCMVMMLBIH-UHFFFAOYSA-N 2-(1-benzyl-2-oxo-5-piperazin-1-yl-4h-quinazolin-3-yl)acetamide;hydrochloride Chemical compound Cl.O=C1N(CC(=O)N)CC2=C(N3CCNCC3)C=CC=C2N1CC1=CC=CC=C1 NATAOCMVMMLBIH-UHFFFAOYSA-N 0.000 description 1
• FFBNJXIYMNIMCF-UHFFFAOYSA-N 2-[1-[(3-fluorophenyl)methyl]-2-oxo-5-piperazin-1-yl-4h-quinazolin-3-yl]acetamide;hydrochloride Chemical compound Cl.O=C1N(CC(=O)N)CC2=C(N3CCNCC3)C=CC=C2N1CC1=CC=CC(F)=C1 FFBNJXIYMNIMCF-UHFFFAOYSA-N 0.000 description 1
• 125000000022 2-aminoethyl group Chemical group [H]C([*])([H])C([H])([H])N([H])[H] 0.000 description 1
• 125000004847 2-fluorobenzyl group Chemical group [H]C1=C([H])C(F)=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
• 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 1
• UPHOPMSGKZNELG-UHFFFAOYSA-N 2-hydroxynaphthalene-1-carboxylic acid Chemical compound C1=CC=C2C(C(=O)O)=C(O)C=CC2=C1 UPHOPMSGKZNELG-UHFFFAOYSA-N 0.000 description 1
• CTOUNZIAEBIWAW-UHFFFAOYSA-N 3,4-dihydro-1h-quinazolin-2-one Chemical compound C1=CC=C2NC(=O)NCC2=C1 CTOUNZIAEBIWAW-UHFFFAOYSA-N 0.000 description 1
• FULAGCKVRGRSDL-UHFFFAOYSA-N 3-[(3-methyl-2-oxo-5-piperazin-1-yl-4h-quinazolin-1-yl)methyl]benzonitrile;hydrochloride Chemical compound Cl.O=C1N(C)CC2=C(N3CCNCC3)C=CC=C2N1CC1=CC=CC(C#N)=C1 FULAGCKVRGRSDL-UHFFFAOYSA-N 0.000 description 1
• DSKICSKEJFCBBE-UHFFFAOYSA-N 3-[(5-bromo-3-methyl-2-oxo-4h-quinazolin-1-yl)methyl]benzonitrile Chemical compound O=C1N(C)CC2=C(Br)C=CC=C2N1CC1=CC=CC(C#N)=C1 DSKICSKEJFCBBE-UHFFFAOYSA-N 0.000 description 1
• BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
• KDYRCLCWOXHASC-UHFFFAOYSA-N 3-ethyl-1-[(4-fluorophenyl)methyl]-5-piperazin-1-yl-4h-quinazolin-2-one;hydrochloride Chemical compound Cl.O=C1N(CC)CC2=C(N3CCNCC3)C=CC=C2N1CC1=CC=C(F)C=C1 KDYRCLCWOXHASC-UHFFFAOYSA-N 0.000 description 1
• SYVNVEGIRVXRQH-UHFFFAOYSA-N 3-fluorobenzoyl chloride Chemical compound FC1=CC=CC(C(Cl)=O)=C1 SYVNVEGIRVXRQH-UHFFFAOYSA-N 0.000 description 1
• QOXOZONBQWIKDA-UHFFFAOYSA-N 3-hydroxypropyl Chemical group [CH2]CCO QOXOZONBQWIKDA-UHFFFAOYSA-N 0.000 description 1
• HFALUFHWCJTWPV-UHFFFAOYSA-N 4-(3-amino-2-cyano-5-methoxyphenyl)piperazine-1-carboxylic acid Chemical compound COC1=CC(N)=C(C#N)C(N2CCN(CC2)C(O)=O)=C1 HFALUFHWCJTWPV-UHFFFAOYSA-N 0.000 description 1
• OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
• KFCSTSWVSLIVMS-UHFFFAOYSA-N 4-ethyl-2,6-dinitrobenzonitrile Chemical group CCC1=CC([N+]([O-])=O)=C(C#N)C([N+]([O-])=O)=C1 KFCSTSWVSLIVMS-UHFFFAOYSA-N 0.000 description 1
• MDOWEUXXLVBZIU-UHFFFAOYSA-N 4-fluoro-2,6-dinitrophenol Chemical compound OC1=C([N+]([O-])=O)C=C(F)C=C1[N+]([O-])=O MDOWEUXXLVBZIU-UHFFFAOYSA-N 0.000 description 1
• CZKLEJHVLCMVQR-UHFFFAOYSA-N 4-fluorobenzoyl chloride Chemical compound FC1=CC=C(C(Cl)=O)C=C1 CZKLEJHVLCMVQR-UHFFFAOYSA-N 0.000 description 1
• 125000004176 4-fluorobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1F)C([H])([H])* 0.000 description 1
• BORWQAYCYKZCNT-UHFFFAOYSA-N 4-methyl-2,6-dinitrobenzonitrile Chemical group CC1=CC([N+]([O-])=O)=C(C#N)C([N+]([O-])=O)=C1 BORWQAYCYKZCNT-UHFFFAOYSA-N 0.000 description 1
• 102000049773 5-HT2A Serotonin Receptor Human genes 0.000 description 1
• 108010072564 5-HT2A Serotonin Receptor Proteins 0.000 description 1
• UWKNBRKBDHTUDX-UHFFFAOYSA-N 5-bromo-1-[(2-fluorophenyl)methyl]-3-methyl-4h-quinazolin-2-one Chemical compound O=C1N(C)CC2=C(Br)C=CC=C2N1CC1=CC=CC=C1F UWKNBRKBDHTUDX-UHFFFAOYSA-N 0.000 description 1
• IMDMJWBMNJCALW-UHFFFAOYSA-N 5-bromo-1-[(4-fluorophenyl)methyl]-3-methyl-4h-quinazolin-2-one Chemical compound O=C1N(C)CC2=C(Br)C=CC=C2N1CC1=CC=C(F)C=C1 IMDMJWBMNJCALW-UHFFFAOYSA-N 0.000 description 1
• 102000040125 5-hydroxytryptamine receptor family Human genes 0.000 description 1
• GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
• 241000271566 Aves Species 0.000 description 1
• 239000005711 Benzoic acid Substances 0.000 description 1
• 241000283690 Bos taurus Species 0.000 description 1
• LFGLYXSCOFCFEV-UHFFFAOYSA-N BrC1=C2CN(CNC2=CC=C1)C Chemical compound BrC1=C2CN(CNC2=CC=C1)C LFGLYXSCOFCFEV-UHFFFAOYSA-N 0.000 description 1
• 0 CC(C)(C)OC(N(CC1)CCN1c1c(*)c(N=O)cc(OC)c1)=O Chemical compound CC(C)(C)OC(N(CC1)CCN1c1c(*)c(N=O)cc(OC)c1)=O 0.000 description 1
• OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
• 241000282472 Canis lupus familiaris Species 0.000 description 1
• 241000283707 Capra Species 0.000 description 1
• 241000700198 Cavia Species 0.000 description 1
• 241000282693 Cercopithecidae Species 0.000 description 1
• RROWWMQHSXFRAB-UHFFFAOYSA-N ClC=1C=C(CN2C(NCC3=C(C=C(C=C23)F)N2CCNCC2)=O)C=CC1 Chemical compound ClC=1C=C(CN2C(NCC3=C(C=C(C=C23)F)N2CCNCC2)=O)C=CC1 RROWWMQHSXFRAB-UHFFFAOYSA-N 0.000 description 1
• RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
• 239000004375 Dextrin Substances 0.000 description 1
• 229920001353 Dextrin Polymers 0.000 description 1
• 239000004338 Dichlorodifluoromethane Substances 0.000 description 1
• MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
• SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 1
• 206010013654 Drug abuse Diseases 0.000 description 1
• KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
• LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 1
• 241000283086 Equidae Species 0.000 description 1
• 241000282326 Felis catus Species 0.000 description 1
• WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
• WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
• 241001272567 Hominoidea Species 0.000 description 1
• 241000282412 Homo Species 0.000 description 1
• DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
• 241000764238 Isis Species 0.000 description 1
• WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
• WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
• FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
• 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
• 241001024304 Mino Species 0.000 description 1
• 229920000881 Modified starch Polymers 0.000 description 1
• TXXHDPDFNKHHGW-CCAGOZQPSA-N Muconic acid Natural products OC(=O)\C=C/C=C\C(O)=O TXXHDPDFNKHHGW-CCAGOZQPSA-N 0.000 description 1
• 241000699670 Mus sp. Species 0.000 description 1
• RFDRKSBHRPUUFM-UHFFFAOYSA-N N#Cc(c([N+]([O-])=O)cc(O)c1)c1[N+]([O-])=O Chemical compound N#Cc(c([N+]([O-])=O)cc(O)c1)c1[N+]([O-])=O RFDRKSBHRPUUFM-UHFFFAOYSA-N 0.000 description 1
• HSHXDCVZWHOWCS-UHFFFAOYSA-N N'-hexadecylthiophene-2-carbohydrazide Chemical compound CCCCCCCCCCCCCCCCNNC(=O)c1cccs1 HSHXDCVZWHOWCS-UHFFFAOYSA-N 0.000 description 1
• 125000003047 N-acetyl group Chemical group 0.000 description 1
• PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 1
• MBBZMMPHUWSWHV-BDVNFPICSA-N N-methylglucamine Chemical compound CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO MBBZMMPHUWSWHV-BDVNFPICSA-N 0.000 description 1
• GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
• 241000283973 Oryctolagus cuniculus Species 0.000 description 1
• 241000282579 Pan Species 0.000 description 1
• 241001494479 Pecora Species 0.000 description 1
• ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
• 241000288906 Primates Species 0.000 description 1
• IWYDHOAUDWTVEP-UHFFFAOYSA-N R-2-phenyl-2-hydroxyacetic acid Natural products OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 1
• 241000700157 Rattus norvegicus Species 0.000 description 1
• 239000002262 Schiff base Substances 0.000 description 1
• 150000004753 Schiff bases Chemical class 0.000 description 1
• KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
• 241000282887 Suidae Species 0.000 description 1
• GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
• 239000007983 Tris buffer Substances 0.000 description 1
• HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
• WTIJJMMJQXQMOR-UHFFFAOYSA-N [dibromo(nitro)methyl]benzene Chemical compound [O-][N+](=O)C(Br)(Br)C1=CC=CC=C1 WTIJJMMJQXQMOR-UHFFFAOYSA-N 0.000 description 1
• 150000001241 acetals Chemical class 0.000 description 1
• 230000002378 acidificating effect Effects 0.000 description 1
• 150000007513 acids Chemical class 0.000 description 1
• 125000004442 acylamino group Chemical group 0.000 description 1
• 125000004423 acyloxy group Chemical group 0.000 description 1
• 239000000853 adhesive Substances 0.000 description 1
• 239000002671 adjuvant Substances 0.000 description 1
• 125000003158 alcohol group Chemical group 0.000 description 1
• 150000001299 aldehydes Chemical group 0.000 description 1
• 229910001413 alkali metal ion Inorganic materials 0.000 description 1
• 125000004450 alkenylene group Chemical group 0.000 description 1
• 230000029936 alkylation Effects 0.000 description 1
• 238000005804 alkylation reaction Methods 0.000 description 1
• BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
• 229910052782 aluminium Inorganic materials 0.000 description 1
• WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
• 125000003277 amino group Chemical group 0.000 description 1
• 238000010171 animal model Methods 0.000 description 1
• 239000008365 aqueous carrier Substances 0.000 description 1
• 239000008135 aqueous vehicle Substances 0.000 description 1
• 235000021311 artificial sweeteners Nutrition 0.000 description 1
• 238000003556 assay Methods 0.000 description 1
• 239000012298 atmosphere Substances 0.000 description 1
• DXZDEAJXVCLRLE-UHFFFAOYSA-N azepin-2-one Chemical compound O=C1C=CC=CC=N1 DXZDEAJXVCLRLE-UHFFFAOYSA-N 0.000 description 1
• 125000003828 azulenyl group Chemical group 0.000 description 1
• 230000003542 behavioural effect Effects 0.000 description 1
• SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 1
• 229940092714 benzenesulfonic acid Drugs 0.000 description 1
• 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 description 1
• 125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 description 1
• 125000004618 benzofuryl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 description 1
• 235000010233 benzoic acid Nutrition 0.000 description 1
• 150000001558 benzoic acid derivatives Chemical class 0.000 description 1
• 125000005874 benzothiadiazolyl group Chemical group 0.000 description 1
• 125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 description 1
• 125000004600 benzothiopyranyl group Chemical group S1C(C=CC2=C1C=CC=C2)* 0.000 description 1
• 125000004622 benzoxazinyl group Chemical group O1NC(=CC2=C1C=CC=C2)* 0.000 description 1
• 125000004541 benzoxazolyl group Chemical group O1C(=NC2=C1C=CC=C2)* 0.000 description 1
• 238000005574 benzylation reaction Methods 0.000 description 1
• WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
• 239000011230 binding agent Substances 0.000 description 1
• 229920002988 biodegradable polymer Polymers 0.000 description 1
• 239000004621 biodegradable polymer Substances 0.000 description 1
• 230000015572 biosynthetic process Effects 0.000 description 1
• 239000004305 biphenyl Substances 0.000 description 1
• 235000010290 biphenyl Nutrition 0.000 description 1
• 238000006664 bond formation reaction Methods 0.000 description 1
• 239000000872 buffer Substances 0.000 description 1
• KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
• 239000011575 calcium Substances 0.000 description 1
• 229910052791 calcium Inorganic materials 0.000 description 1
• AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
• 239000000920 calcium hydroxide Substances 0.000 description 1
• 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
• 150000004657 carbamic acid derivatives Chemical class 0.000 description 1
• 125000002837 carbocyclic group Chemical group 0.000 description 1
• 150000001721 carbon Chemical group 0.000 description 1
• 150000001722 carbon compounds Chemical class 0.000 description 1
• 239000001569 carbon dioxide Substances 0.000 description 1
• 235000011089 carbon dioxide Nutrition 0.000 description 1
• 229910002092 carbon dioxide Inorganic materials 0.000 description 1
• 229960004424 carbon dioxide Drugs 0.000 description 1
• 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
• KYKAJFCTULSVSH-UHFFFAOYSA-N chloro(fluoro)methane Chemical compound F[C]Cl KYKAJFCTULSVSH-UHFFFAOYSA-N 0.000 description 1
• 238000004587 chromatography analysis Methods 0.000 description 1
• 230000019771 cognition Effects 0.000 description 1
• 238000013270 controlled release Methods 0.000 description 1
• 238000007796 conventional method Methods 0.000 description 1
• DOBRDRYODQBAMW-UHFFFAOYSA-N copper(i) cyanide Chemical compound [Cu+].N#[C-] DOBRDRYODQBAMW-UHFFFAOYSA-N 0.000 description 1
• 239000012043 crude product Substances 0.000 description 1
• 238000002425 crystallisation Methods 0.000 description 1
• 230000008025 crystallization Effects 0.000 description 1
• 150000003997 cyclic ketones Chemical class 0.000 description 1
• 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
• 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
• 125000000596 cyclohexenyl group Chemical group C1(=CCCCC1)* 0.000 description 1
• 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
• 125000002433 cyclopentenyl group Chemical group C1(=CCCC1)* 0.000 description 1
• 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
• 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
• 230000007850 degeneration Effects 0.000 description 1
• 230000018044 dehydration Effects 0.000 description 1
• 238000006297 dehydration reaction Methods 0.000 description 1
• 238000010511 deprotection reaction Methods 0.000 description 1
• 238000013461 design Methods 0.000 description 1
• 238000011161 development Methods 0.000 description 1
• 235000019425 dextrin Nutrition 0.000 description 1
• 239000008121 dextrose Substances 0.000 description 1
• 125000002576 diazepinyl group Chemical group N1N=C(C=CC=C1)* 0.000 description 1
• PXBRQCKWGAHEHS-UHFFFAOYSA-N dichlorodifluoromethane Chemical compound FC(F)(Cl)Cl PXBRQCKWGAHEHS-UHFFFAOYSA-N 0.000 description 1
• 235000019404 dichlorodifluoromethane Nutrition 0.000 description 1
• 229940042935 dichlorodifluoromethane Drugs 0.000 description 1
• 229940087091 dichlorotetrafluoroethane Drugs 0.000 description 1
• 235000014113 dietary fatty acids Nutrition 0.000 description 1
• ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
• 125000004852 dihydrofuranyl group Chemical group O1C(CC=C1)* 0.000 description 1
• 125000005045 dihydroisoquinolinyl group Chemical group C1(NC=CC2=CC=CC=C12)* 0.000 description 1
• 125000005043 dihydropyranyl group Chemical group O1C(CCC=C1)* 0.000 description 1
• 125000005044 dihydroquinolinyl group Chemical group N1(CC=CC2=CC=CC=C12)* 0.000 description 1
• USIUVYZYUHIAEV-UHFFFAOYSA-N diphenyl ether Chemical group C=1C=CC=CC=1OC1=CC=CC=C1 USIUVYZYUHIAEV-UHFFFAOYSA-N 0.000 description 1
• KZTYYGOKRVBIMI-UHFFFAOYSA-N diphenyl sulfone Chemical group C=1C=CC=CC=1S(=O)(=O)C1=CC=CC=C1 KZTYYGOKRVBIMI-UHFFFAOYSA-N 0.000 description 1
• 238000004821 distillation Methods 0.000 description 1
• 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
• 238000012377 drug delivery Methods 0.000 description 1
• 239000002702 enteric coating Substances 0.000 description 1
• 238000009505 enteric coating Methods 0.000 description 1
• 210000002615 epidermis Anatomy 0.000 description 1
• CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 1
• 125000005678 ethenylene group Chemical group [H]C([*:1])=C([H])[*:2] 0.000 description 1
• LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 1
• 229940093471 ethyl oleate Drugs 0.000 description 1
• 239000000284 extract Substances 0.000 description 1
• 239000000194 fatty acid Substances 0.000 description 1
• 229930195729 fatty acid Natural products 0.000 description 1
• 238000001914 filtration Methods 0.000 description 1
• 235000019634 flavors Nutrition 0.000 description 1
• 125000003983 fluorenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3CC12)* 0.000 description 1
• 235000013355 food flavoring agent Nutrition 0.000 description 1
• 235000019253 formic acid Nutrition 0.000 description 1
• 238000004108 freeze drying Methods 0.000 description 1
• 239000001530 fumaric acid Substances 0.000 description 1
• 230000006870 function Effects 0.000 description 1
• 238000002825 functional assay Methods 0.000 description 1
• 125000000524 functional group Chemical group 0.000 description 1
• 125000002541 furyl group Chemical group 0.000 description 1
• 239000007789 gas Substances 0.000 description 1
• 210000001035 gastrointestinal tract Anatomy 0.000 description 1
• 239000003349 gelling agent Substances 0.000 description 1
• 239000000174 gluconic acid Substances 0.000 description 1
• 235000012208 gluconic acid Nutrition 0.000 description 1
• 235000013922 glutamic acid Nutrition 0.000 description 1
• 239000004220 glutamic acid Substances 0.000 description 1
• 235000011187 glycerol Nutrition 0.000 description 1
• 239000008187 granular material Substances 0.000 description 1
• 229940093915 gynecological organic acid Drugs 0.000 description 1
• 125000006492 halo alkyl aryl group Chemical group 0.000 description 1
• 125000004438 haloalkoxy group Chemical group 0.000 description 1
• 125000004476 heterocycloamino group Chemical group 0.000 description 1
• 239000008240 homogeneous mixture Substances 0.000 description 1
• 150000004677 hydrates Chemical class 0.000 description 1
• 230000036571 hydration Effects 0.000 description 1
• 238000006703 hydration reaction Methods 0.000 description 1
• 150000003840 hydrochlorides Chemical class 0.000 description 1
• 238000005984 hydrogenation reaction Methods 0.000 description 1
• 230000007062 hydrolysis Effects 0.000 description 1
• 238000006460 hydrolysis reaction Methods 0.000 description 1
• 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
• 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
• 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
• 238000005417 image-selected in vivo spectroscopy Methods 0.000 description 1
• 125000002632 imidazolidinyl group Chemical group 0.000 description 1
• 125000002636 imidazolinyl group Chemical group 0.000 description 1
• 125000002883 imidazolyl group Chemical group 0.000 description 1
• 239000007943 implant Substances 0.000 description 1
• 238000011065 in-situ storage Methods 0.000 description 1
• 125000003454 indenyl group Chemical group C1(C=CC2=CC=CC=C12)* 0.000 description 1
• 125000001041 indolyl group Chemical group 0.000 description 1
• 229940060367 inert ingredients Drugs 0.000 description 1
• 229940102223 injectable solution Drugs 0.000 description 1
• 150000007529 inorganic bases Chemical class 0.000 description 1
• 238000012739 integrated shape imaging system Methods 0.000 description 1
• 230000003993 interaction Effects 0.000 description 1
• 238000001361 intraarterial administration Methods 0.000 description 1
• 238000007918 intramuscular administration Methods 0.000 description 1
• 238000007913 intrathecal administration Methods 0.000 description 1
• 238000001990 intravenous administration Methods 0.000 description 1
• 125000002346 iodo group Chemical group I* 0.000 description 1
• 150000002500 ions Chemical class 0.000 description 1
• 208000002551 irritable bowel syndrome Diseases 0.000 description 1
• 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
• 125000000904 isoindolyl group Chemical group C=1(NC=C2C=CC=CC12)* 0.000 description 1
• 238000002955 isolation Methods 0.000 description 1
• 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
• 125000002183 isoquinolinyl group Chemical group C1(=NC=CC2=CC=CC=C12)* 0.000 description 1
• 125000001786 isothiazolyl group Chemical group 0.000 description 1
• 125000003965 isoxazolidinyl group Chemical group 0.000 description 1
• 125000000842 isoxazolyl group Chemical group 0.000 description 1
• 229960005417 ketanserin Drugs 0.000 description 1
• 150000002576 ketones Chemical class 0.000 description 1
• 239000004310 lactic acid Substances 0.000 description 1
• 235000014655 lactic acid Nutrition 0.000 description 1
• 150000002632 lipids Chemical class 0.000 description 1
• 229910052744 lithium Inorganic materials 0.000 description 1
• 239000000314 lubricant Substances 0.000 description 1
• 239000011777 magnesium Substances 0.000 description 1
• 229910052749 magnesium Inorganic materials 0.000 description 1
• ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
• 239000001095 magnesium carbonate Substances 0.000 description 1
• 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
• 235000019359 magnesium stearate Nutrition 0.000 description 1
• 239000001630 malic acid Substances 0.000 description 1
• 235000011090 malic acid Nutrition 0.000 description 1
• 229960002510 mandelic acid Drugs 0.000 description 1
• 238000001819 mass spectrum Methods 0.000 description 1
• 230000001404 mediated effect Effects 0.000 description 1
• 108020004999 messenger RNA Proteins 0.000 description 1
• 229910052987 metal hydride Inorganic materials 0.000 description 1
• 150000004681 metal hydrides Chemical class 0.000 description 1
• 229910021645 metal ion Inorganic materials 0.000 description 1
• 125000000250 methylamino group Chemical group [H]N(*)C([H])([H])[H] 0.000 description 1
• 239000008108 microcrystalline cellulose Substances 0.000 description 1
• 229940016286 microcrystalline cellulose Drugs 0.000 description 1
• 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
• 150000007522 mineralic acids Chemical class 0.000 description 1
• 238000002156 mixing Methods 0.000 description 1
• 230000004048 modification Effects 0.000 description 1
• 238000012986 modification Methods 0.000 description 1
• 235000019426 modified starch Nutrition 0.000 description 1
• 239000002324 mouth wash Substances 0.000 description 1
• 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
• KVBGVZZKJNLNJU-UHFFFAOYSA-N naphthalene-2-sulfonic acid Chemical compound C1=CC=CC2=CC(S(=O)(=O)O)=CC=C21 KVBGVZZKJNLNJU-UHFFFAOYSA-N 0.000 description 1
• 125000004593 naphthyridinyl group Chemical group N1=C(C=CC2=CC=CN=C12)* 0.000 description 1
• 229920003052 natural elastomer Polymers 0.000 description 1
• 229920001194 natural rubber Polymers 0.000 description 1
• 235000021096 natural sweeteners Nutrition 0.000 description 1
• 230000000926 neurological effect Effects 0.000 description 1
• 239000002858 neurotransmitter agent Substances 0.000 description 1
• 229910017604 nitric acid Inorganic materials 0.000 description 1
• 125000002560 nitrile group Chemical group 0.000 description 1
• 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
• 231100000252 nontoxic Toxicity 0.000 description 1
• 230000003000 nontoxic effect Effects 0.000 description 1
• 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
• 235000008390 olive oil Nutrition 0.000 description 1
• 239000004006 olive oil Substances 0.000 description 1
• 239000006186 oral dosage form Substances 0.000 description 1
• 150000007524 organic acids Chemical class 0.000 description 1
• 235000005985 organic acids Nutrition 0.000 description 1
• 150000007530 organic bases Chemical class 0.000 description 1
• 150000002895 organic esters Chemical class 0.000 description 1
• 125000000962 organic group Chemical group 0.000 description 1
• 238000006053 organic reaction Methods 0.000 description 1
• 239000003960 organic solvent Substances 0.000 description 1
• 125000001715 oxadiazolyl group Chemical group 0.000 description 1
• 125000000160 oxazolidinyl group Chemical group 0.000 description 1
• 125000002971 oxazolyl group Chemical group 0.000 description 1
• 150000002923 oximes Chemical class 0.000 description 1
• 125000004430 oxygen atom Chemical group O* 0.000 description 1
• 150000002940 palladium Chemical class 0.000 description 1
• FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
• 238000007911 parenteral administration Methods 0.000 description 1
• 235000015927 pasta Nutrition 0.000 description 1
• 230000007170 pathology Effects 0.000 description 1
• 239000001814 pectin Substances 0.000 description 1
• 235000010987 pectin Nutrition 0.000 description 1
• 229920001277 pectin Polymers 0.000 description 1
• 239000003961 penetration enhancing agent Substances 0.000 description 1
• 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
• 125000005010 perfluoroalkyl group Chemical group 0.000 description 1
• 239000000825 pharmaceutical preparation Substances 0.000 description 1
• 230000000144 pharmacologic effect Effects 0.000 description 1
• 125000005561 phenanthryl group Chemical group 0.000 description 1
• 125000000286 phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
• 229910000073 phosphorus hydride Inorganic materials 0.000 description 1
• 150000004885 piperazines Chemical class 0.000 description 1
• 125000003386 piperidinyl group Chemical group 0.000 description 1
• IUGYQRQAERSCNH-UHFFFAOYSA-N pivalic acid Chemical compound CC(C)(C)C(O)=O IUGYQRQAERSCNH-UHFFFAOYSA-N 0.000 description 1
• 229910052697 platinum Inorganic materials 0.000 description 1
• 239000002798 polar solvent Substances 0.000 description 1
• 229920000747 poly(lactic acid) Polymers 0.000 description 1
• 239000004626 polylactic acid Substances 0.000 description 1
• 229910052700 potassium Inorganic materials 0.000 description 1
• 239000011591 potassium Substances 0.000 description 1
• 235000011056 potassium acetate Nutrition 0.000 description 1
• WSHYKIAQCMIPTB-UHFFFAOYSA-M potassium;2-oxo-3-(3-oxo-1-phenylbutyl)chromen-4-olate Chemical compound [K+].[O-]C=1C2=CC=CC=C2OC(=O)C=1C(CC(=O)C)C1=CC=CC=C1 WSHYKIAQCMIPTB-UHFFFAOYSA-M 0.000 description 1
• BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
• 239000003380 propellant Substances 0.000 description 1
• 230000000069 prophylactic effect Effects 0.000 description 1
• 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
• WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical group CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 description 1
• 239000003586 protic polar solvent Substances 0.000 description 1
• 125000001042 pteridinyl group Chemical group N1=C(N=CC2=NC=CN=C12)* 0.000 description 1
• 230000002685 pulmonary effect Effects 0.000 description 1
• 125000000561 purinyl group Chemical group N1=C(N=C2N=CNC2=C1)* 0.000 description 1
• 125000004309 pyranyl group Chemical group O1C(C=CC=C1)* 0.000 description 1
• 125000003373 pyrazinyl group Chemical group 0.000 description 1
• 125000003072 pyrazolidinyl group Chemical group 0.000 description 1
• 125000003226 pyrazolyl group Chemical group 0.000 description 1
• 125000002098 pyridazinyl group Chemical group 0.000 description 1
• 125000005495 pyridazyl group Chemical group 0.000 description 1
• 125000005576 pyrimidinylene group Chemical group 0.000 description 1
• HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical compound O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 description 1
• 150000004040 pyrrolidinones Chemical class 0.000 description 1
• 125000000719 pyrrolidinyl group Chemical group 0.000 description 1
• 125000000168 pyrrolyl group Chemical group 0.000 description 1
• 125000002294 quinazolinyl group Chemical group N1=C(N=CC2=CC=CC=C12)* 0.000 description 1
• 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 description 1
• 125000001567 quinoxalinyl group Chemical group N1=C(C=NC2=CC=CC=C12)* 0.000 description 1
• 239000000376 reactant Substances 0.000 description 1
• 230000001105 regulatory effect Effects 0.000 description 1
• 238000011160 research Methods 0.000 description 1
• 239000011347 resin Substances 0.000 description 1
• 229920005989 resin Polymers 0.000 description 1
• 210000002345 respiratory system Anatomy 0.000 description 1
• 238000007363 ring formation reaction Methods 0.000 description 1
• 229960004889 salicylic acid Drugs 0.000 description 1
• 229960004499 scopolamine hydrobromide Drugs 0.000 description 1
• WTGQALLALWYDJH-MOUKNHLCSA-N scopolamine hydrobromide (anhydrous) Chemical compound Br.C1([C@@H](CO)C(=O)O[C@H]2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 WTGQALLALWYDJH-MOUKNHLCSA-N 0.000 description 1
• 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
• 229940076279 serotonin Drugs 0.000 description 1
• 229920002379 silicone rubber Polymers 0.000 description 1
• 239000004945 silicone rubber Substances 0.000 description 1
• 239000002002 slurry Substances 0.000 description 1
• 239000011734 sodium Substances 0.000 description 1
• 229910052708 sodium Inorganic materials 0.000 description 1
• 229910000029 sodium carbonate Inorganic materials 0.000 description 1
• 239000007909 solid dosage form Substances 0.000 description 1
• 239000001593 sorbitan monooleate Substances 0.000 description 1
• 235000011069 sorbitan monooleate Nutrition 0.000 description 1
• 229940035049 sorbitan monooleate Drugs 0.000 description 1
• 230000003595 spectral effect Effects 0.000 description 1
• 238000005728 strengthening Methods 0.000 description 1
• 208000011117 substance-related disease Diseases 0.000 description 1
• 150000003461 sulfonyl halides Chemical class 0.000 description 1
• 239000004094 surface-active agent Substances 0.000 description 1
• 238000001356 surgical procedure Methods 0.000 description 1
• 230000002459 sustained effect Effects 0.000 description 1
• 230000005062 synaptic transmission Effects 0.000 description 1
• 238000003786 synthesis reaction Methods 0.000 description 1
• 229920003051 synthetic elastomer Polymers 0.000 description 1
• 239000005061 synthetic rubber Substances 0.000 description 1
• 239000006188 syrup Substances 0.000 description 1
• 235000020357 syrup Nutrition 0.000 description 1
• 239000000454 talc Substances 0.000 description 1
• 229910052623 talc Inorganic materials 0.000 description 1
• AOYYNFQYNCSMNZ-UHFFFAOYSA-N tert-butyl 4-(1-benzyl-2-oxo-4h-3,1-benzoxazin-5-yl)piperazine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCN1C1=CC=CC2=C1COC(=O)N2CC1=CC=CC=C1 AOYYNFQYNCSMNZ-UHFFFAOYSA-N 0.000 description 1
• UOUFRTFWWBCVPV-UHFFFAOYSA-N tert-butyl 4-(2,4-dioxo-1H-thieno[3,2-d]pyrimidin-3-yl)piperidine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCC(CC1)n1c(=O)[nH]c2ccsc2c1=O UOUFRTFWWBCVPV-UHFFFAOYSA-N 0.000 description 1
• DOVNPMXRMJDILV-UHFFFAOYSA-N tert-butyl 4-(3-amino-2-cyano-5-methoxyphenyl)piperazine-1-carboxylate Chemical compound COC1=CC(N)=C(C#N)C(N2CCN(CC2)C(=O)OC(C)(C)C)=C1 DOVNPMXRMJDILV-UHFFFAOYSA-N 0.000 description 1
• DAXRWZOUPNQURF-UHFFFAOYSA-N tert-butyl 4-(3-benzamido-2-cyanophenyl)piperazine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCN1C1=CC=CC(NC(=O)C=2C=CC=CC=2)=C1C#N DAXRWZOUPNQURF-UHFFFAOYSA-N 0.000 description 1
• ABVYQLDWUFPBIN-UHFFFAOYSA-N tert-butyl 4-[1-[(3-fluorophenyl)methyl]-3-methyl-2-oxo-4h-quinazolin-5-yl]piperazine-1-carboxylate Chemical compound O=C1N(C)CC2=C(N3CCN(CC3)C(=O)OC(C)(C)C)C=CC=C2N1CC1=CC=CC(F)=C1 ABVYQLDWUFPBIN-UHFFFAOYSA-N 0.000 description 1
• SSIKFESYWPVPFT-UHFFFAOYSA-N tert-butyl 4-[1-[(4-fluorophenyl)methyl]-2-oxo-3,4-dihydroquinazolin-5-yl]piperazine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCN1C1=CC=CC2=C1CNC(=O)N2CC1=CC=C(F)C=C1 SSIKFESYWPVPFT-UHFFFAOYSA-N 0.000 description 1
• JVCWBHWUDIAHAK-UHFFFAOYSA-N tert-butyl 4-[2-(aminomethyl)-3-[(2,3-dichlorophenyl)methylamino]phenyl]piperazine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCN1C1=CC=CC(NCC=2C(=C(Cl)C=CC=2)Cl)=C1CN JVCWBHWUDIAHAK-UHFFFAOYSA-N 0.000 description 1
• KNFGZLORTGCZDO-UHFFFAOYSA-N tert-butyl 4-[2-(aminomethyl)-3-[(2,3-difluorophenyl)methylamino]phenyl]piperazine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCN1C1=CC=CC(NCC=2C(=C(F)C=CC=2)F)=C1CN KNFGZLORTGCZDO-UHFFFAOYSA-N 0.000 description 1
• BFUKMQGHUHVOAM-UHFFFAOYSA-N tert-butyl 4-[2-(aminomethyl)-3-[(2-chlorophenyl)methylamino]phenyl]piperazine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCN1C1=CC=CC(NCC=2C(=CC=CC=2)Cl)=C1CN BFUKMQGHUHVOAM-UHFFFAOYSA-N 0.000 description 1
• NGDVGQVVLCVDQD-UHFFFAOYSA-N tert-butyl 4-[2-(aminomethyl)-3-[(2-fluorophenyl)methylamino]phenyl]piperazine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCN1C1=CC=CC(NCC=2C(=CC=CC=2)F)=C1CN NGDVGQVVLCVDQD-UHFFFAOYSA-N 0.000 description 1
• LAUVNZDTOJXQCH-UHFFFAOYSA-N tert-butyl 4-[2-(aminomethyl)-3-[(2-methylphenyl)methylamino]phenyl]piperazine-1-carboxylate Chemical compound CC1=CC=CC=C1CNC1=CC=CC(N2CCN(CC2)C(=O)OC(C)(C)C)=C1CN LAUVNZDTOJXQCH-UHFFFAOYSA-N 0.000 description 1
• IQWGKWVIRDDRJV-UHFFFAOYSA-N tert-butyl 4-[2-(aminomethyl)-3-[(3,4-dichlorophenyl)methylamino]phenyl]piperazine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCN1C1=CC=CC(NCC=2C=C(Cl)C(Cl)=CC=2)=C1CN IQWGKWVIRDDRJV-UHFFFAOYSA-N 0.000 description 1
• YYKNKQPEPPYFDJ-UHFFFAOYSA-N tert-butyl 4-[2-(aminomethyl)-3-[(3,4-difluorophenyl)methylamino]phenyl]piperazine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCN1C1=CC=CC(NCC=2C=C(F)C(F)=CC=2)=C1CN YYKNKQPEPPYFDJ-UHFFFAOYSA-N 0.000 description 1
• GZOKSDBSESXBPI-UHFFFAOYSA-N tert-butyl 4-[2-(aminomethyl)-3-[(3-chloro-2-fluorophenyl)methylamino]phenyl]piperazine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCN1C1=CC=CC(NCC=2C(=C(Cl)C=CC=2)F)=C1CN GZOKSDBSESXBPI-UHFFFAOYSA-N 0.000 description 1
• IEQNTPLSYXJVDI-UHFFFAOYSA-N tert-butyl 4-[2-(aminomethyl)-3-[(3-chlorophenyl)methylamino]phenyl]piperazine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCN1C1=CC=CC(NCC=2C=C(Cl)C=CC=2)=C1CN IEQNTPLSYXJVDI-UHFFFAOYSA-N 0.000 description 1
• WYAVLADTXWCUJF-UHFFFAOYSA-N tert-butyl 4-[2-(aminomethyl)-3-[(3-fluorophenyl)methylamino]phenyl]piperazine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCN1C1=CC=CC(NCC=2C=C(F)C=CC=2)=C1CN WYAVLADTXWCUJF-UHFFFAOYSA-N 0.000 description 1
• GMSGGXCXCUFBCR-UHFFFAOYSA-N tert-butyl 4-[2-(aminomethyl)-3-[(3-methylphenyl)methylamino]phenyl]piperazine-1-carboxylate Chemical compound CC1=CC=CC(CNC=2C(=C(N3CCN(CC3)C(=O)OC(C)(C)C)C=CC=2)CN)=C1 GMSGGXCXCUFBCR-UHFFFAOYSA-N 0.000 description 1
• VHKZGINFJOLWTB-UHFFFAOYSA-N tert-butyl 4-[2-(aminomethyl)-3-[(4-chlorophenyl)methylamino]phenyl]piperazine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCN1C1=CC=CC(NCC=2C=CC(Cl)=CC=2)=C1CN VHKZGINFJOLWTB-UHFFFAOYSA-N 0.000 description 1
• AFSGXSBOJCGMTH-UHFFFAOYSA-N tert-butyl 4-[2-cyano-3-[(2,3-difluorobenzoyl)amino]phenyl]piperazine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCN1C1=CC=CC(NC(=O)C=2C(=C(F)C=CC=2)F)=C1C#N AFSGXSBOJCGMTH-UHFFFAOYSA-N 0.000 description 1
• PDOWRQFIARXHGZ-UHFFFAOYSA-N tert-butyl 4-[2-cyano-3-[(2-methylbenzoyl)amino]phenyl]piperazine-1-carboxylate Chemical compound CC1=CC=CC=C1C(=O)NC1=CC=CC(N2CCN(CC2)C(=O)OC(C)(C)C)=C1C#N PDOWRQFIARXHGZ-UHFFFAOYSA-N 0.000 description 1
• CDQXHPOBVJLIQO-UHFFFAOYSA-N tert-butyl 4-[2-cyano-3-[(3,4-difluorobenzoyl)amino]phenyl]piperazine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCN1C1=CC=CC(NC(=O)C=2C=C(F)C(F)=CC=2)=C1C#N CDQXHPOBVJLIQO-UHFFFAOYSA-N 0.000 description 1
• DDKBKLVTRAUVND-UHFFFAOYSA-N tert-butyl 4-[2-cyano-3-[(3-fluorobenzoyl)amino]phenyl]piperazine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCN1C1=CC=CC(NC(=O)C=2C=C(F)C=CC=2)=C1C#N DDKBKLVTRAUVND-UHFFFAOYSA-N 0.000 description 1
• PZSXCAIGAXBWIY-UHFFFAOYSA-N tert-butyl 4-[2-cyano-3-[(3-methylbenzoyl)amino]phenyl]piperazine-1-carboxylate Chemical compound CC1=CC=CC(C(=O)NC=2C(=C(N3CCN(CC3)C(=O)OC(C)(C)C)C=CC=2)C#N)=C1 PZSXCAIGAXBWIY-UHFFFAOYSA-N 0.000 description 1
• PVORCZXVRJLPHG-UHFFFAOYSA-N tert-butyl 4-[3-[(2-chlorobenzoyl)amino]-2-cyanophenyl]piperazine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCN1C1=CC=CC(NC(=O)C=2C(=CC=CC=2)Cl)=C1C#N PVORCZXVRJLPHG-UHFFFAOYSA-N 0.000 description 1
• KBBDRZFTGIFALU-UHFFFAOYSA-N tert-butyl 4-[3-[(3-chloro-2-fluorobenzoyl)amino]-2-cyanophenyl]piperazine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCN1C1=CC=CC(NC(=O)C=2C(=C(Cl)C=CC=2)F)=C1C#N KBBDRZFTGIFALU-UHFFFAOYSA-N 0.000 description 1
• ORKAARKKQGILRJ-UHFFFAOYSA-N tert-butyl 4-[3-[(3-chlorobenzoyl)amino]-2-cyanophenyl]piperazine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCN1C1=CC=CC(NC(=O)C=2C=C(Cl)C=CC=2)=C1C#N ORKAARKKQGILRJ-UHFFFAOYSA-N 0.000 description 1
• JEISWTZHCQHSIW-UHFFFAOYSA-N tert-butyl 4-[3-[(4-chlorobenzoyl)amino]-2-cyanophenyl]piperazine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCN1C1=CC=CC(NC(=O)C=2C=CC(Cl)=CC=2)=C1C#N JEISWTZHCQHSIW-UHFFFAOYSA-N 0.000 description 1
• 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
• 125000003718 tetrahydrofuranyl group Chemical group 0.000 description 1
• 125000003039 tetrahydroisoquinolinyl group Chemical group C1(NCCC2=CC=CC=C12)* 0.000 description 1
• 125000001412 tetrahydropyranyl group Chemical group 0.000 description 1
• 125000000147 tetrahydroquinolinyl group Chemical group N1(CCCC2=CC=CC=C12)* 0.000 description 1
• 229940124597 therapeutic agent Drugs 0.000 description 1
• 230000001225 therapeutic effect Effects 0.000 description 1
• 125000005304 thiadiazolidinyl group Chemical group 0.000 description 1
• 125000001113 thiadiazolyl group Chemical group 0.000 description 1
• 125000006090 thiamorpholinyl sulfone group Chemical group 0.000 description 1
• 125000006089 thiamorpholinyl sulfoxide group Chemical group 0.000 description 1
• 125000000335 thiazolyl group Chemical group 0.000 description 1
• 230000008719 thickening Effects 0.000 description 1
• 125000005297 thienyloxy group Chemical group S1C(=CC=C1)O* 0.000 description 1
• 125000004568 thiomorpholinyl group Chemical group 0.000 description 1
• 230000000699 topical effect Effects 0.000 description 1
• 230000037317 transdermal delivery Effects 0.000 description 1
• 238000012546 transfer Methods 0.000 description 1
• 238000011269 treatment regimen Methods 0.000 description 1
• 125000004306 triazinyl group Chemical group 0.000 description 1
• 125000001425 triazolyl group Chemical group 0.000 description 1
• 229940029284 trichlorofluoromethane Drugs 0.000 description 1
• 125000004044 trifluoroacetyl group Chemical group FC(C(=O)*)(F)F 0.000 description 1
• 229960000281 trometamol Drugs 0.000 description 1
• 239000006216 vaginal suppository Substances 0.000 description 1
• 235000015112 vegetable and seed oil Nutrition 0.000 description 1
• 239000008158 vegetable oil Substances 0.000 description 1
• 239000011345 viscous material Substances 0.000 description 1
• 239000000080 wetting agent Substances 0.000 description 1
• 229910052725 zinc Inorganic materials 0.000 description 1
• 239000011701 zinc Substances 0.000 description 1